{"title":"Pharmacology","description":"","products":[{"product_id":"9780471497271","title":"Combinatorial Strategies in Biology and Chemistry","description":"\u003ch1\u003eCombinatorial Strategies in Biology and Chemistry\u003c\/h1\u003e\u003ch3\u003eAnnette Beck-Sickinger | Peter Weber\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Life Sciences \/ Biology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eDieses Buch führt die Molekularbiologie und die kombinatorische Chemie in absolut praxistauglicher Weise zusammen. Spezialisten aus der Chemie oder der Biologie wird der Einstieg in die Kombinatorik leicht gemacht! Eine große Vielfalt von Themen und Verfahren vermittelt schnell und effektiv einen Überblick über ein spannendes und aufstrebendes Gebiet.\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eAnnette Gabriele Beck-Sickinger\u003c\/b\u003e is a German chemist and biologist. She has been a full professor of Biochemistry and Bioorganic Chemistry at the University of Leipzig since 1999.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePeter Weber\u003c\/b\u003e is the author of \u003ci\u003eCombinatorial Strategies in Biology and Chemistry\u003c\/i\u003e, published by Wiley.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e28 January 2002\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471497271\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e11.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310332932236,"sku":"9780471497271","price":108.86,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471497271_4e45631e-97b4-48cf-a827-8ce31e30e049.jpg?v=1780158818"},{"product_id":"9780813806495","title":"Dense Phase Carbon Dioxide Food and Pharmaceutical Applications","description":"\u003ch1\u003eDense Phase Carbon Dioxide\u003c\/h1\u003e\u003ch2\u003eFood and Pharmaceutical Applications\u003c\/h2\u003e\u003ch3\u003eMurat O. Balaban | Giovanna Ferrentino\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eTechnology \u0026amp; Engineering \/ Food Science \/ General\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003eDense phase carbon dioxide (DPCD) is a non-thermal method for food and pharmaceutical processing that can ensure safe products with minimal nutrient loss and better preserved quality attributes. Its application is quite different than, for example, supercritical extraction with CO 2 where the typical solubility of materials in CO 2 is in the order of 1% and therefore requires large volumes of CO 2. In contrast, processing with DPCD requires much less CO 2 (between 5 to 8% CO 2 by weight) and the pressures used are at least one order of magnitude less than those typically used in ultra high pressure (UHP) processing. There is no noticeable temperature increase due to pressurization, and typical process temperatures are around 40°C.\u003c\/p\u003e \u003cp\u003eDPCD temporarily reduces the pH of liquid foods and because oxygen is removed from the environment, and because the temperature is not high during the short process time (typically about five minutes in continuous systems), nutrients, antioxidant activity, and vitamins are much better preserved than with thermal treatments. In pharmaceutical applications, DPCD facilitates the production of micronized powders of controlled particle size and distribution. Although the capital and operating costs are higher than that of thermal treatments, they are much lower than other non-thermal technology operations.\u003c\/p\u003e \u003cp\u003eThis book is the first to bring together the significant amount of research into DPCD and highlight its effectiveness against microorganisms and enzymes as well as its potential in particle engineering. It is directed at food and pharmaceutical industry scientists and technologists working with DPCD and other traditional or non-thermal technologies that can potentially be used in conjunction with DPCD. It will also be of interest to packaging specialists and regulatory agencies.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e Murat O Balaban, PhD is Professor of Food Processing and Engineering in the Food Science and Human Nutrition Department, University of Florida, Gainesville, FL. Current research areas include food processing and engineering with emphasis on supercritical fluid technology; mathematical modeling and computer vision applications, thermal processing and reaction kinetics; ohmic thawing; and seafood processing and technology. Dr. Balaban holds five US patents, including one for the inactivation of enzymes in foods with pressurized CO2 and another for the method and apparatus for continuous flow reduction of microbial and\/or enzymatic activity in a liquid beer product using carbon dioxide.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e19 June 2012\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780813806495\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e336\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e28.98\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310352068748,"sku":"9780813806495","price":228.56,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780813806495.jpg?v=1780162543"},{"product_id":"9780471943914","title":"Clinical Measurement in Drug Evaluation","description":"\u003ch1\u003eClinical Measurement in Drug Evaluation\u003c\/h1\u003e\u003ch3\u003eWalter S. Nimmo | Geoffrey T. Tucker\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pharmacology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eInternationally renowned authorities from diverse fields present the principles and practice regarding the measurement of drug effects in humans and its role in the analysis and development of new chemical entities. The main thrust is on surrogate endpoints, peripheral vascular disease, the reliability of data collection and interpretation as well as the identification, predictability and performance of drug interactions and adverse effects.\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eWalter S. Nimmo\u003c\/b\u003e is the editor of \u003ci\u003eClinical Measurement in Drug Evaluation\u003c\/i\u003e, published by Wiley.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eGeoffrey T. Tucker\u003c\/b\u003e is the editor of \u003ci\u003eClinical Measurement in Drug Evaluation\u003c\/i\u003e, published by Wiley.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e06 September 1995\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471943914\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e344\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e23.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310369861772,"sku":"9780471943914","price":464.36,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471943914_9dd88569-5a94-4f6b-874d-7ce349ce23ba.jpg?v=1780103419"},{"product_id":"9781405167901","title":"ABC of Stroke","description":"\u003ch3\u003eABC Series\u003c\/h3\u003e\u003ch1\u003eABC of Stroke\u003c\/h1\u003e\u003ch3\u003eJonathan Mant | Marion F. Walker\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Neurology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eStroke is the most common cause of adult disability and is of increasing importance within ageing populations. \u003cp\u003eThis brand new title in the \u003ci\u003eABC\u003c\/i\u003e series covers the entire patient journey, from prevention through to long-term support. It includes primary prevention and management of risk factors for stroke and secondary prevention including pharmaceutical, lifestyle and surgical intervention. The general principles of stroke rehabilitation are also addressed as well as mobility, communication and psychological problems, as is stroke in younger people. It also covers long-term support for stroke survivors and their carers.\u003c\/p\u003e \u003cp\u003eThis is an invaluable and practical guide to all aspects of stroke for both health care professionals and lay audiences. It is of particular relevance to general practitioners, junior doctors, nurses and therapists working with stroke patients and their carers, and to people with stroke and their families.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e \u003cp\u003eThis title is also available as a mobile App from MedHand Mobile Libraries. Buy it now from \u003ca href=\"https:\/\/play.google.com\/store\/apps\/details?id=net.medhand.wabcs\u0026amp;hl=en\"\u003eGoogle Play\u003c\/a\u003e or the \u003ca href=\"https:\/\/www.medhand.com\/products\/abc-of-stroke\"\u003eMedHand Store\u003c\/a\u003e.\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cb\u003eJonathan Mant\u003c\/b\u003e, Associate Director UK Stroke Research Network and Professor of Primary Care Research, Addenbrooke’s Hospital, University of Cambridge, UK  \u003cp\u003e\u003cb\u003eMarion F Walker\u003c\/b\u003e, Associate Director UK Stroke Research Network and Professor in Stroke Rehabilitation, University of Nottingham, UK\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e25 April 2011\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eBMJ Books\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781405167901\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e80\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e9.28\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310491005068,"sku":"9781405167901","price":36.86,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781405167901_43fe1954-bad5-4eb3-95b6-90910d5568ed.jpg?v=1780158994"},{"product_id":"9780566084911","title":"Drugs Synonyms and Properties","description":"\u003ch1\u003eDrugs\u003c\/h1\u003e\u003ch2\u003eSynonyms and Properties\u003c\/h2\u003e\u003ch3\u003eG. W. A. Milne\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Industrial \u0026amp; Technical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eDrugs: Synonyms and Properties provides comprehensive coverage of the 10,000 drugs currently in common use worldwide. Its overall organization and inclusion of detailed chemical information fills an important gap in drug information. This reference, edited by a world-renowned authority in drug design and chemical information and now in its second edition, has become one of the bibles of pharmaceutical research and application.\u003cbr\u003e \u003cbr\u003e This book organizes the 10,000 drugs currently in use by therapeutic category. Therefore all tranquilizers, all antidepressants, or all anorexic agents, for example, are grouped together. In all, 204 categories are represented. This arrangement means that all drugs in a given category can be reviewed very easily and their relative properties compared quickly.\u003cbr\u003e \u003cbr\u003e A key component of this reference is the extensive coverage of synonyms. The book includes an index of over 30,000 drug synonyms and trade names with a cross-reference to their main entry. This extraordinarily comprehensive view of trade names and generic synonyms makes Drugs: Synonyms and Properties one of the world's most exhaustive references in its field.\u003cbr\u003e \u003cbr\u003e For each main entry, the following information is provided: chemical name and a list of trade names and synonyms; the Chemical Abstracts Service (CAS) Registry Number; the European Inventory of Existing Commercial Chemical Substances (EINECS) Number; the Merck Index (Twelfth Edition) Number; the physical properties of each compound; and the known biological activity and indicated applications. Indexes, including a master index of names and synonyms, and of manufacturers and suppliers, are appended.\u003cbr\u003e \u003cbr\u003e This reference will be invaluable to research chemists, biologists, and physicians and to anyone interested in drugs who, starting with a single synonym for a drug, will be able to quickly find a thumbnail sketch of the essential information concerning that agent.\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cb\u003eG W A MILNE\u003c\/b\u003e was a Senior Researcher at the National Institutes of Health in Bethesda, MD, USA for 35 years where he worked on the use of spectroscopy for structure determination of organic compounds, and on molecular modeling in the design of drugs for the treatment of cancer and AIDS. From 1980 until 1998 he worked in molecular modeling and information technology at the National Cancer Institute, one of the NIH Institutes. He has been active for many years in the fields of chemical information and chemical computation and is the Editor of the American Chemical Society's Journal of \u003ci\u003eChemical Information and Computer Science\u003c\/i\u003e and Gardner's \u003ci\u003eChemical Synonyms and Trade Names\u003c\/i\u003e, Eleventh Edition (Ashgate). \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e01 February 2002\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Spektrum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780566084911\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e1136\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e60.32\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310491725964,"sku":"9780566084911","price":289.76,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780566084911.jpg?v=1780159114"},{"product_id":"9780470281765","title":"Compatibility of Pharmaceutical Solutions and Contact Materials Safety Assessments of Extractables and Leachables for Pharmaceutical Products","description":"\u003ch1\u003eCompatibility of Pharmaceutical Solutions and Contact Materials\u003c\/h1\u003e\u003ch2\u003eSafety Assessments of Extractables and Leachables for Pharmaceutical Products\u003c\/h2\u003e\u003ch3\u003eDennis Jenke\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pharmacology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cb\u003e\u003ci\u003eImportant safety aspects of compatibility for therapeutic products and their manufacturing systems, delivery devices, and containers\u003c\/i\u003e\u003c\/b\u003e  \u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eCompatibility of Pharmaceutical Products and Contact Materials\u003c\/i\u003e helps pharmaceutical, toxicology, analytical, and regulatory affairs professionals assess the safety of leachable and extractable chemicals associated with drug product packaging, manufacturing systems, and devices. The most comprehensive resource available, its coverage includes the strategies, tactics, and regulatory requirements for performing safety assessments, along with the means for interpreting results. \u003c\/p\u003e\n\u003cp\u003eStructured around a logical framework for an extractables and leachables safety assessment and closely linked to the pharmaceutical product development process, \u003ci\u003eCompatibility of Pharmaceutical Products and Contact Materials\u003c\/i\u003e directly addresses the fundamental questions of \"what activities need to be performed to completely, efficiently, and effectively address the issue of product safety from an extractables and leachables perspective?\" and \"when do the various required activities need to be performed?\" Specifically, the chapters describe: \u003c\/p\u003e\n\u003cul\u003e \u003cli\u003ePertinent regulations and practical ways to meet guidelines\u003c\/li\u003e \u003cli\u003eCoordinating manufacturing, storage, and delivery systems development and qualification with therapeutic product development\u003c\/li\u003e \u003cli\u003eMaterials characterization and the materials screening process\u003c\/li\u003e \u003cli\u003eComponent and\/or system qualification (illustrated by several case studies)\u003c\/li\u003e \u003cli\u003ePerforming validation\/migration studies and interpreting and reporting the results\u003c\/li\u003e \u003cli\u003eCreating a product registration dossier and putting it through regulatory review\u003c\/li\u003e \u003cli\u003eProduct maintenance (Change Control) from an extractables and leachables perspective\u003c\/li\u003e \u003cli\u003eLikely future developments in extractables and leachables assessment\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eAdditionally, the book's appendix provides a database, including CAS registry numbers, chemical formulas and molecular weights of extractable\/leachable substances that have been reported in the chemical literature. \u003c\/p\u003e\n\u003cp\u003eDetailing the interconnected roles played by analytical chemistry, biological science, toxicology, and regulatory science, \u003ci\u003eCompatibility of Pharmaceutical Products and Contact Materials\u003c\/i\u003e supplies a much-needed, comprehensive resource to all those in pharmaceutical product or medical device development.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cb\u003eDENNIS JENKE\u003c\/b\u003e is Principal Scientist in the Technology Resources Division of the Baxter Healthcare Corporation. He works with a team of analytical chemistry professionals in areas including the assessment of material\/product compatibility, specifically with respect to leachables\/extractables and product ingredient binding. He has published extensively in the areas of analytical chemistry, environmental science, and material\/solution compatibility; serves as an expert reviewer for numerous pharmaceutical and analytical journals; is a frequently invited speaker in the general areas of analytical chemistry and material\/solution compatibility; and is currently an active participant in ongoing collaborative activities designed to establish harmonized best demonstrated practices for extractables\/leachables assessment. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e02 June 2009\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Interscience\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470281765\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e400\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e23.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310511026316,"sku":"9780470281765","price":145.76,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470281765.jpg?v=1780160755"},{"product_id":"9780470976364","title":"Essentials of Pharmaceutical Preformulation","description":"\u003ch1\u003eEssentials of Pharmaceutical Preformulation\u003c\/h1\u003e\u003ch3\u003eSimon Gaisford | Mark Saunders\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Biotechnology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003e\u003ci\u003eEssentials of Pharmaceutical Preformulation\u003c\/i\u003e is a study guide which describes the basic principles of pharmaceutical physicochemical characterisation. Successful preformulation requires knowledge of fundamental molecular concepts (solubility, ionisation, partitioning, hygroscopicity and stability) and macroscopic properties (physical form, such as the crystalline and amorphous states, hydrates, solvates and co-crystals and powder properties), familiarity with the techniques used to measure them and appreciation of their effect on product performance, recognising that often there is a position of compromise to be reached between product stability and bioavailability.\u003c\/p\u003e \u003cp\u003eThis text introduces the basic concepts and discusses their wider implication for pharmaceutical development, with reference to many case examples of current drugs and drug products. Special attention is given to the principles and best-practice of the analytical techniques that underpin preformulation (UV spectrophotometry, TLC, DSC, XRPD and HPLC). The material is presented in the typical order that would be followed when developing a medicine and maps onto the indicative pharmacy syllabus of the Royal Pharmaceutical Society of Great Britain\u003c\/p\u003e \u003cp\u003eUndergraduate-level pharmacy students and R\u0026amp;D \/ analytical scientists working in the pharmaceutical sector (with or without a pharmaceutical background) will find this text easy to follow with relevant pharmaceutical examples.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eEssential study guide for pharmacy and pharmaceutical science students\u003c\/li\u003e \u003cli\u003eCovers the pharmaceutical preformulation components of the Royal Pharmaceutical Society of Great Britain’s indicative syllabus\u003c\/li\u003e \u003cli\u003eEasy to follow text highlighted with relevant pharmaceutical examples\u003c\/li\u003e \u003cli\u003eSelf-assessment assignments in a variety of formats\u003c\/li\u003e \u003cli\u003eWritten by authors with both academic and industrial experience\u003c\/li\u003e \u003cli\u003eCompanion website with further information to maximise learning\u003c\/li\u003e \u003c\/ul\u003e\n\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eDr Simon Gaisford\u003c\/b\u003e from the University of London. Dr. Gaisford is a senior lecturer in Pharmaceutics. His research interests include: Thermal analysis, isothermal calorimetry, differential scanning calorimetry (DSC), solution calorimetry, titration calorimetry (ITC), dynamic mechanical analysis (DMA), thermal ink-jetting, polymorphism, amorphous content quantification, inhalation, oral fast-dissolving films, personalised-dose medicines\u003c\/p\u003e \u003cp\u003e\u003cb\u003eMark Saunders\u003c\/b\u003e was awarded his first degree in Biological and Medicinal Chemistry from the University of Exeter and his PhD from the London School of Pharmacy under the supervision of Professors Kevin Taylor and Duncan Craig. His PhD programme was sponsored by GlaxoSmithKline and involved the design and characterisation of novel injectable lipid-based carrier vehicles for the treatment of Cystic Fibrosis.\u003cbr\u003eAfter finishing his PhD, Mark consulted for the London based legal firm SJ Berwin, providing independant laboratory services in support of a successful major patent litigation trial on Paxil (Paroxetine Hydrochloride). After this, Mark was appointed Physical Scientist at a London based Contract Research Organisation (CRO), where he oversaw the growth and development of the company through to a commercial sell in 2007.\u003cbr\u003eAfter spending 5 years in the Research and Development support arm of the company and having set up both the Physical Properties and Screening laboratories, Mark moved into Strategic Development where he directly lead the successful set up of a Japanese Business Development office in Tokyo. After 2 years in this position and havng seen the company grow significantly, Mark moved from this role and was involved in the commercial set up of Kuecept Ltd, of which he is a co-founder. Mark is also a member of UK and US Controlled Release Societies, Royal Society of Chemistry, Association of Pharmaceutical Scientists (APS), Internation Society of Aerosol Medicines, sits on the committee of the APS Materials Science Focus Group and has co-authored over 20 peer reviewed papers and 2 book chapters on preformulation.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e04 January 2013\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470976364\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e268\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e18.4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310512730252,"sku":"9780470976364","price":87.26,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470976364_5eac834f-907d-4b96-983a-0edc2d87257b.jpg?v=1780198115"},{"product_id":"9780470976838","title":"Pharmaceutical Emulsions A Drug Developer's Toolbag","description":"\u003ch1\u003ePharmaceutical Emulsions\u003c\/h1\u003e\u003ch2\u003eA Drug Developer's Toolbag\u003c\/h2\u003e\u003ch3\u003eDipak Kumar Sarkar\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Biotechnology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003ci\u003ePharmaceutical Emulsions: A Drug Developer's Toolbag\u003c\/i\u003e covers all the key aspects of pharmaceutical emulsions, starting from the fundamental scientific basics, to the pharmaceutical forms and the chemical tests for its application. The author uses his extensive experience in both industry and academic experience to provide a concise, student friendly guide to the essential fundamentals of physical pharmacy.  \u003cp\u003eDivided into three clear sections, the text begins with Section A - \u003ci\u003eConsideration for Product: Medicinal Formulation\u003c\/i\u003e which includes a historical perspective, explanation of what is an emulsion, stability and instability, and manufacture. Section B - \u003ci\u003eForms, Use and Application\u003c\/i\u003e follows, with chapters on creams and ointments, pastes and bases, colloids, transdermal, gels and implants. The final Section, \u003ci\u003eTests: Chemistry to control the quality\u003c\/i\u003e, efficacy and fitness for purpose of the product includes chapters on physic-chemical properties, sizing and microscopy, rheology, QC and finally questions, calculations and dilemmas. Throughout the text there are numerous figures, diagrams and tables to engage the reader.\u003c\/p\u003e \u003cp\u003eThis is an invaluable reference for all students of pharmaceutical sciences, pharmacy industrial pharmaceutical sciences, physical pharmacy and pharmaceutical forms as well as industry professionals\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003eDipak K. Sarker\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eSchool of Pharmacy and Biomolecular Sciences, University of Brighton, UK\u003c\/i\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e21 October 2013\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470976838\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e206\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e16.96\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310598582412,"sku":"9780470976838","price":126.85,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470976838.jpg?v=1780165964"},{"product_id":"9781394212637","title":"Mushroom Biotechnology for Improved Agriculture and Human Health","description":"\u003ch1\u003eMushroom Biotechnology for Improved Agriculture and Human Health\u003c\/h1\u003e\u003ch3\u003eCharles Oluwaseun Adetunji | Chukwuebuka Egbuna | Oluwatosin Ademola Ijabadeniyi | Samantha C. Karunarathna\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Life Sciences \/ Genetics \u0026amp; Genomics\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cb\u003eThe book is essential for those seeking to understand innovative and sustainable solutions to global food insecurity and health challenges, as it offers invaluable insights into the transformative potential of mushroom biotechnology and its applications. \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe intervention of microbial biotechnology in various sectors has displayed remarkable growth linked to sustainable innovations and biotechnological utilization of beneficial microorganisms, such as mushrooms, for the benefit of humanity. Recent advancements in mushroom biotechnology will prove successful due to mushrooms’ nature as natural problem solvers, including their ability to enhance nutritional values obtained from agricultural crops, sustained health benefits derived from pharmacologically active substances used to manage human diseases, and improve crop production.\u003c\/p\u003e \u003cp\u003eThis book will serve as one of the first volumes addressing the usefulness of mushroom biotechnology, giving detailed state-of-the-art information on recent advancements and how the industry could maximize profits. The volume will also assist the pharmaceutical and medical sectors by examining the discovery of novel pharmacological and bioactive compounds that could replace the various adverse effects when using synthetic drugs. It presents a simple, adaptable, reproducible methodology that will help researchers and scientists adopt these methodologies for similar projects.\u003c\/p\u003e \u003cp\u003eReaders will find that the book:\u003c\/p\u003e \u003cul\u003e \u003cli\u003ePresents recent advances in the application of mushroom biotechnology in various sectors (food, agriculture, and health) for sustainable innovations for optimum benefit of mankind;\u003c\/li\u003e \u003cli\u003eDetails applications of mushrooms for sustainable agriculture through their plant growth-promoting attributes and management of pests and diseases in plants and soils;\u003c\/li\u003e \u003cli\u003eDiscusses the discovery of novel pharmacological substances from mushrooms for applications in the biomedical sector.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003cb\u003eAudience\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe book is valuable reference work for scientists and researchers working in the fields of pharmaceutical sciences, agricultural microbiology, plant pathology, botany, agriculture, microbiology, biotechnology, nanotechnology, environmental microbiology, and microbial biotechnology.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cb\u003eCharles Oluwaseun Adetunji, PhD\u003c\/b\u003e, is a professor in the Department of Microbiology at the Edo University Iyamho, in Edo State, Nigeria. Currently, he is the Director of Intellectual Properties and Technology Transfer and Chairman of the Committee on Research Grants at EUI. He has won several scientific awards and grants from renowned academic bodies such as the Council of Scientific and Industrial Research (CSIR) India. He has published more than 600 papers in peer-reviewed national and international journals as well as more than 50 books, 340 book chapters, and many scientific patents. \u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eChukwuebuka Egbuna, PhD,\u003c\/b\u003e is a chartered chemist and academic researcher. He has published numerous articles in international journals of repute and edited over 20 internationally published books. He serves as a reviewer and editorial board member of several journals and a member of the Institute of Chartered Chemists of Nigeria, the Nigerian Society of Biochemistry and Molecular Biology, and the Royal Society of Chemistry. His primary research interests include biochemistry, phytochemistry, pharmacology, nutrition and toxicology, food and medicinal chemistry, and analytical biochemistry.  \u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eOluwatosin Ademola Ijabadeniyi, PhD,\u003c\/b\u003e is a professor in the Department of Biotechnology and Food Science, Durban University of Technology, South Africa. He has published numerous scientific papers, edited one book, and authored four books. His work in this field has also earned him several awards including an Association of Commonwealth Universities fellowship and an Association of Public Health Libraries Centers for Disease Control fellowship. \u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSamantha C. Karunarathna, PhD,\u003c\/b\u003e is a professor at Qujing Normal University, China. He has published over 360 publications and co-authored two books. His current research interests are taxonomy, phylogeny, and domestication of wild edible and medicinal mushrooms.  \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e28 May 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Scrivener\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781394212637\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e400\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e26.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310626435212,"sku":"9781394212637","price":212.36,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781394212637.jpg?v=1780165276"},{"product_id":"9781405133586","title":"Sheffield Analytical Chemistry Series","description":"\u003ch1\u003eSheffield Analytical Chemistry Series\u003c\/h1\u003e\u003ch2\u003e\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eContributors:\u003c\/strong\u003e Smith, Richard J.; Webb, Michael L.\u003c\/p\u003e\u003cp\u003eA key component of the overall quality of a pharmaceutical is control of impurities, as their presence, even in small amounts, may affect drug safety and efficacy. The identification and quantification of impurities to acceptable standards presents a significant challenge to the analytical chemist. Analytical science is developing rapidly and provides increasing opportunity to identify the structure, and therefore the origin and safety implications of these impurities, and the challenges of their measurement drives the development of modern quantitative methods. \u003cbr\u003e \u003c\/p\u003e\u003cp\u003eWritten for both practicing and student analytical chemists, \u003ci\u003eAnalysis of Drug Impurities\u003c\/i\u003e provides a detailed overview of the challenges and the techniques available to permit accurate identification and quantification of drug impurities.\u003c\/p\u003e\u003ch3\u003eBook Details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePublisher:\u003c\/strong\u003e Wiley-Blackwell\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e 2007-04-30\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e Hardcover\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eISBN-13:\u003c\/strong\u003e 9781405133586\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePages:\u003c\/strong\u003e 288\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":44310627680396,"sku":"9781405133586","price":211.46,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781405133586_20eafd00-6361-4e20-8dd2-9e57ae31a2a4.jpg?v=1768917715"},{"product_id":"9780566084119","title":"Chiral Drugs","description":"\u003ch1\u003eChiral Drugs\u003c\/h1\u003e\u003ch3\u003eCynthia A. Challener\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Industrial \u0026amp; Technical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eIn the early twentieth century the relevance of chirality to the pharmaceutical industry was established by the fact that one enantiomer of hyoscyamine possessed greater pharmacological activity than the other.\u003cbr\u003e \u003cbr\u003e Today, most new drugs and those under development consist of a single optically active isomer, and chirality is also becoming an issue for the agrochemical and other industries. Regulatory agencies throughout the world are currently reviewing the importance of chirality with regard to pharmaceutical and agrochemical products. New guidelines from such agencies have been key drivers for the focus on single enantiomer products in these industries.\u003cbr\u003e \u003cbr\u003e These scientific and regulatory developments have created the need for a guide for workers in the pharmaceutical and chemical industries seeking information on chiral molecules, processes, and commercially available chiral chemicals. Chiral Drugs is a comprehensive listing of over 2500 chiral drugs, classified by therapeutic class, and including structures and physical properties for each entry in the listing. Its companion volume, Chiral Intermediates, presents the same detailed information for over 4700 commercially available chiral chemicals.\u003cbr\u003e \u003cbr\u003e The 'Chiral Pool' of readily available, relatively inexpensive chiral compounds has been expanding at a rapid rate as more and more products are produced in large quantities at economical prices. New developments in various technologies for isolating, preparing, and purifying chiral materials have greatly increased the opportunities for utilizing optically pure compounds in commercial applications. Novel techniques for classical resolution, new methodologies for developing selective enzymes for biocatalysis, advances in the application of microorganisms for chemical production, and continued progress in the area of asymmetric synthesis have all contributed to the growth of this field.\u003cbr\u003e \u003cbr\u003e Part One of each book contains four chapters which provide an introduction to topics relevant to the field of chiral chemistry and includes a brief overview of chirality, a short discussion on the current market drivers in the area of chiral chemistry, and a basic presentation of the various sources and methods for obtaining chiral compounds.\u003cbr\u003e \u003cbr\u003e Part Two presents entries for over 2500 chiral drugs, classified by therapeutic class. For each main entry, the chemical name and a list of trade names and synonyms is provided; the CAS Registry Number, the European Inventory of Existing Commercial Chemical Substances (EINECS) number, and the Merck Index (12th edition) number are given when available. The physical properties, including specific rotation, of each compound are described and indicated applications are presented. The structure of nearly every compound is provided, and the manufacturers and suppliers of the compounds are also given. Indexes, including a master index of names and synonyms and an index of custom manufacturing services for production of chiral compounds, are appended.\u003cbr\u003e \u003cbr\u003e Chiral Drugs provides an introduction to the types of sources and methods currently in use for obtaining chiral molecules and is an invaluable resource for researchers in the pharmaceutical and biotechnology sectors as well as to those working in the basic biochemical sciences. Chiral Intermediates provides an introduction to the types of sources and methods currently in use for obtaining chiral molecules and is an invaluable resource for information on available chiral molecules. Chiral Intermediates and Chiral Drugs are the most comprehensive and detailed guides to chiral compounds available.\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003eCynthia A Challener\u003c\/b\u003e currently works as a freelance writer and information management consultant to the chemical industry. She has had experience in research and development, technical support, regulatory compliance, marketing and document and information management. Cynthia received her BS in Chemistry in 1986 from Stanford University and her PhD in Organic Chemistry in 1990 from the University of Chicago.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e01 December 2001\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780566084119\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e672\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e45.7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310674276492,"sku":"9780566084119","price":251.96,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780566084119_8871eae9-4dda-4bd7-9f12-137617150a1e.jpg?v=1780146895"},{"product_id":"9780566084126","title":"Chiral Intermediates","description":"\u003ch1\u003eChiral Intermediates\u003c\/h1\u003e\u003ch3\u003eCynthia A. Challener\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Industrial \u0026amp; Technical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eIn the early twentieth century the relevance of chirality to the pharmaceutical industry was established by the fact that one enantiomer of hyoscyamine possessed greater pharmacological activity than the other. Today, most new drugs and those under development consist of a single optically active isomer, and chirality is also becoming an issue for the agrochemical and other industries. Regulatory agencies throughout the world are currently reviewing the importance of chirality with regard to pharmaceutical and agrochemical products. New guidelines from such agencies have been key drivers for the focus on single enantiomer products in these industries.\u003cbr\u003e \u003cbr\u003e These scientific and regulatory developments have created the need for a guide for workers in the pharmaceutical and chemical industries seeking information on chiral molecules, processes, and commercially available chiral chemicals. Chiral Intermediates presents the chemical professional with a comprehensive listing of over 4700 available chiral chemicals including specific data of interest for each entry in the listing. Its companion volume, Chiral Drugs presents the same detailed information for over 2000 chiral drugs.\u003cbr\u003e \u003cbr\u003e The 'Chiral Pool' of readily available, relatively inexpensive chiral compounds has been expanding at a rapid rate as more and more products are produced in large quantities at economical prices. New developments in various technologies for isolating, preparing, and purifying chiral materials have greatly increased the opportunities for utilizing optically pure compounds in commercial applications. Novel techniques for classical resolution, new methodologies for developing selective enzymes for biocatalysis, advances in the application of microorganisms for chemical production, and continued progress in the area of asymmetric synthesis have all contributed to the growth of this field.\u003cbr\u003e \u003cbr\u003e Part I contains four chapters which provide an introduction to topics relevant to the field of chiral chemistry and includes a brief overview of chirality, a short discussion on the current market drivers in the area of chiral chemistry, and a basic presentation of the various sources and methods for obtaining chiral compounds.\u003cbr\u003e \u003cbr\u003e Part II presents entries for 4700 commercially available chiral compounds. For each main entry, the chemical name and a list of trade names and synonyms is provided; the CAS Registry Number, the European Inventory of Existing Commercial Chemical Substances (EINECS) number, and the Merck Index (12th edition) number are given when available. The physical properties, including specific rotation, of each compound are described and indicated applications are presented. The structure of nearly every compound is provided, and the manufacturers and suppliers of the compounds are also given. Indexes, including a master index of names and synonyms and an index of custom manufacturing services for production of chiral compounds, are appended.\u003cbr\u003e \u003cbr\u003e Chiral Intermediates provides an introduction to the types of sources and methods currently in use for obtaining chiral molecules and is an invaluable resource for information on available chiral molecules. Chiral Intermediates and Chiral Drugs are the most comprehensive and detailed guides to chiral compounds available.\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003eCynthia A. Challener\u003c\/b\u003e currently works as a freelance writer and information management consultant to the chemical industry. She has had experience in research and development, technical support, regulatory compliance, marketing and document and information management. Cynthia received her BS in Chemistry in 1986 from Stanford University and her PhD in Organic Chemistry in 1990 from the University of Chicago.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e01 September 2001\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780566084126\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e828\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e56.48\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310675587212,"sku":"9780566084126","price":492.26,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780566084126_85c1960e-81aa-4ca3-a45b-f1c2c5007996.jpg?v=1780170215"},{"product_id":"9780470599143","title":"Solid-Phase Organic Synthesis Concepts, Strategies, and Applications","description":"\u003ch1\u003eSolid-Phase Organic Synthesis\u003c\/h1\u003e\u003ch2\u003eConcepts, Strategies, and Applications\u003c\/h2\u003e\u003ch3\u003ePatrick H. Toy | Yulin Lam\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Physical \u0026amp; Theoretical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cb\u003ePresents both the fundamental concepts and the most recent applications in solid-phase organic synthesis\u003c\/b\u003e \u003cp\u003eWith its emphasis on basic concepts, \u003ci\u003eSolid-Phase Organic Synthesis\u003c\/i\u003e guides readers through all the steps needed to design and perform successful solid-phase organic syntheses. The authors focus on the fundamentals of heterogeneous supports in the synthesis of organic molecules, explaining the use of a solid material to facilitate organic synthesis. This comprehensive text not only presents the fundamentals, but also reviews the most recent research findings and applications, offering readers everything needed to conduct their own state-of-the-art science experiments.\u003c\/p\u003e \u003cp\u003eFeaturing chapters written by leading researchers in the field, \u003ci\u003eSolid-Phase Organic Synthesis\u003c\/i\u003e is divided into two parts:\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003e\u003cb\u003ePart One\u003c\/b\u003e, Concepts and Strategies, discusses the linker groups used to attach the synthesis substrate to the solid support, colorimetric tests to identify the presence of functional groups, combinatorial synthesis, and diversity-oriented synthesis. Readers will discover how solid-phase synthesis is currently used to facilitate the discovery of new molecular functionality. The final chapter discusses how using a support can change or increase reaction selectivity.\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003e\u003cb\u003ePart Two\u003c\/b\u003e, Applications, presents examples of the solid-phase synthesis of various classes of organic molecules. Chapters explore general asymmetric synthesis on a support, strategies for heterocyclic synthesis, and synthesis of radioactive organic molecules, dyes, dendrimers, and oligosaccharides.\u003c\/p\u003e \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eEach chapter ends with a set of conclusions that underscore the key concepts and methods. References in each chapter enable readers to investigate any topic in greater depth.\u003c\/p\u003e \u003cp\u003eWith its presentation of basic concepts as well as recent findings and applications, \u003ci\u003eSolid-Phase Organic Synthesis\u003c\/i\u003e is the ideal starting point for students and researchers in organic, medicinal, and combinatorial chemistry who want to take full advantage of current solid-phase synthesis techniques.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cb\u003ePATRICK H. TOY, P\u003csmall\u003eH\u003c\/small\u003eD,\u003c\/b\u003e is an Associate Professor in the Department of Chemistry at the University of Hong Kong, where he was recognized as an Outstanding Young Researcher. Dr. Toy's review of the Mitsunobu reaction is one of the most frequently downloaded articles ever published in Chemistry-An Asian Journal. \u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eYULIN LAM, P\u003csmall\u003eH\u003c\/small\u003eD,\u003c\/b\u003e is an Associate Professor in the Department of Chemistry at the National University of Singapore. Dr. Lam is a reviewer for several major journals and is an Editorial Advisory Board member of ACS Combinatorial Science. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e18 January 2012\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470599143\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e568\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e41.6\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310875209868,"sku":"9780470599143","price":161.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470599143_193766a9-5374-472d-8b9d-4b4b87ddbd19.jpg?v=1780204660"},{"product_id":"9780816907809","title":"Guidelines for Process Safety in Batch Reaction Systems","description":"\u003ch1\u003eGuidelines for Process Safety in Batch Reaction Systems\u003c\/h1\u003e\u003ch3\u003eCCPS (Center for Chemical Process Safety)\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eTechnology \u0026amp; Engineering \/ Industrial Health \u0026amp; Safety\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eBatch reaction systems pose unique challenges to process safety managers because they do not operate in a steady state. The sequence of processing steps, and frequent start-ups and shutdowns, increase the possibility of human errors and equipment failures. And, since batch plants are often designed for shared use, frequent modification of piping and layout may occur, resulting in complex \"management of change\" issues. This book identifies the singular concerns of batch reaction systems—including potential sources of unsafe conditions—and provides a \"how-to\" guide for the practicing engineer in dealing with them by applying appropriate practices to prevent accidents.\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003eThe CENTER FOR CHEMICAL PROCESS SAFETY (CCPS),\u003c\/b\u003e an industry technology alliance of the American Institute of Chemical Engineers (AIChE), has been a world leader in developing and disseminatinginformation on process safety management and technology since 1985. CCPS has published over 80 books in its process safety guidelines and process safety concepts series. For more information, visit www.ccpsonline.org.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e15 September 1999\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-AIChE\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780816907809\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e196\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e15.46\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310875373708,"sku":"9780816907809","price":170.96,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780816907809.jpg?v=1780204693"},{"product_id":"9780787953072","title":"Global Health Care Markets A Comprehensive Guide to Regions, Trends, and Opportunities Shaping the International Health Arena","description":"\u003ch1\u003eGlobal Health Care Markets\u003c\/h1\u003e\u003ch2\u003eA Comprehensive Guide to Regions, Trends, and Opportunities Shaping the International Health Arena\u003c\/h2\u003e\u003ch3\u003eWalter W. Wieners\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eHealth \u0026amp; Fitness \/ Health Care Issues\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eKeeping in step with the ever expanding global economy, health care providers and pharmaceutical companies are establishing themselves in foreign health markets at an unprecedented rate. The question is, How can these organizations prepare themselves for the challenges and opportunities they will find in today's worldwide health care marketplace? Written by an international panel of highly acclaimed health care experts, Global Health Care Markets is a comprehensive guide to the current state of health care delivery systems worldwide. This much-needed resource profiles the world's most significant regions and markets, analyzes the important trends in international medicine and technology, and provides helpful projections of the opportunities for providers, vendors, agencies, and governments.\u003c\/div\u003e\u003cdiv\u003e  WALTER WIENERS is principal of Walter W. Wieners \u0026amp; Associates, a health care management consulting practice focused on Internet technology. Wieners has consulted abroad extensively and held senior-level positions with two of the major health care information technology consulting firms: First Consulting Group and Superior Consultant Company. He is a frequent speaker on health information technology and global health care markets.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e13 November 2000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eJossey-Bass\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780787953072\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e448\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e27.04\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310906142860,"sku":"9780787953072","price":99.86,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780787953072_4c6f5206-090d-4665-ac2d-cf8775c6925a.jpg?v=1780234336"},{"product_id":"9780470057193","title":"The Chemistry of Organomagnesium Compounds, 2 Volume Set","description":"\u003ch3\u003ePatai's Chemistry of Functional Groups\u003c\/h3\u003e\u003ch1\u003eThe Chemistry of Organomagnesium Compounds, 2 Volume Set\u003c\/h1\u003e\u003ch3\u003eZvi Rappoport | Ilan Marek\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Organic\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eMagnesium remains almost unique among the metals in its ability to react directly with a wide variety of compounds. This organic chemistry field has seen steady progress, and a volume on this topic is long overdue.  In the tradition of the Patai Series this title treats all aspects of functional groups, containing chapters on the theoretical and computational foundations; on analytical and spectroscopic aspects with dedicated chapters on Mass Spectrometry, NMR, IR\/UV, etc.; on reaction mechanisms; on applications in syntheses. Depending on the functional group there are also chapters on industrial use, on effects in biological and\/or environmental systems. Since the area of Organomagnesium Chemistry continues to grow far beyond the classical Grignard Reagents, this is an essential resource to help the reader keep abreast of the latest developments.\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eProfessor Zvi Rappoport\u003c\/b\u003e, Department of Organic Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIlan Marek\u003c\/b\u003e is Professor of Chemistry at the Technion - Israel Institute of Technology. He was educated in France and received his PhD thesis in 1988 from the University Pierre et Marie Curie, Paris. He has been visiting Professor at the University de Montreal (Canada); University of Strasbourg (France); University Paris-Descartes (France); California Institute of Technology (USA) and at the Ecole Nationale Superieure de Chimie de Montpellier (France). He was a member of the International Scientific Committee of the European Symposium on Organic Chemistry (ESOC), including the position of Chairman (2007-2009) and is currently the chairman of the division of organic chemistry, European Association of Chemical and Molecular Sciences (EuCheMS).\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e21 April 2008\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470057193\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e944\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e57.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310926098572,"sku":"9780470057193","price":1256.36,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470057193.jpg?v=1780234633"},{"product_id":"9781405158251","title":"Bulk Solids Handling Equipment Selection and Operation","description":"\u003ch1\u003eBulk Solids Handling\u003c\/h1\u003e\u003ch2\u003eEquipment Selection and Operation\u003c\/h2\u003e\u003ch3\u003eDon McGlinchey\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ General\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003eHandling of powders and bulk solids is a critical industrial technology across a broad spectrum of industries, from minerals processing to bulk and fine chemicals, and the food and pharmaceutical industries.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eBulk Solids Handling: Equipment Selection and Operation\u003c\/i\u003e provides an overview of the major technologies involved in the storage and handling of particulate materials from large grains to fine cohesive materials. Topics covered include characterisation of individual particles and bulk particulate materials, silo design for strength and flow, pneumatic conveying systems, mechanical conveying, and small scale operations. Guidance is given on appropriate equipment choices depending on the type of material to be handled, and applications and limitations of current bulk solids handling equipment are discussed. The reader will then be in a better position to diagnose solids handling and processing problems in industry, and to deal with experts and equipment suppliers from an informed standpoint.\u003c\/p\u003e \u003cp\u003eWith contributions from leading academic and industry experts, the book is essential for anyone who has responsibility for handling, storage, processing or production involving particulate materials. It is designed to be equally applicable to engineers, scientists and technologists, working in for example agriculture, construction, food, bulk and fine chemicals industries, minerals and metals, pharmaceuticals, power generation and waste handling.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cb\u003eDr Don McGlinchey\u003c\/b\u003e is a Reader at the Centre for Industrial Bulk Solids Handling at Glasgow Caledonian University, Glasgow, UK.\u003cbr\u003e \u003cp\u003e\u003cb\u003eContributors:\u003cbr\u003e \u003c\/b\u003eMr Lyn Bates\u003cbr\u003e Dr John W. Carson\u003cbr\u003e Mr Andrew Cowell\u003cbr\u003e Professor Mark Jones\u003cbr\u003e Dr Don McGlinchey\u003cbr\u003e Dr David Mills\u003cbr\u003e Professor J. Michael Rotter\u003cbr\u003e Dr Nayland Stanley-Wood\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e05 May 2008\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781405158251\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e304\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e28.8\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311049765004,"sku":"9781405158251","price":192.56,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781405158251_496cf57c-6677-4149-bc96-ca3cfb757f28.jpg?v=1780108216"},{"product_id":"9783527340750","title":"Applied Bioengineering Innovations and Future Directions","description":"\u003ch3\u003eAdvanced Biotechnology\u003c\/h3\u003e\u003ch1\u003eApplied Bioengineering\u003c\/h1\u003e\u003ch2\u003eInnovations and Future Directions\u003c\/h2\u003e\u003ch3\u003eToshiomi Yoshida | Sang Yup Lee | Jens Nielsen | Gregory Stephanopoulos\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Biotechnology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eHochaktuelle und zukünftige Ausrichtungen von fünf Kernbereichen der Biotechnik, die für eine nachhaltige und innovative Produktion von unmittelbarer Bedeutung sind.\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003eToshiomi Yoshida\u003c\/b\u003e is Professor Emeritus of Osaka University (Japan). He received his doctorate degree at the same university in 1968, after studying fermentation technology. From 1972 to 1973, he visited the University of Pennsylvania (USA) for a research stay. In the further course of his career, he became Associate Professor at Osaka University in 1978, Full Professor in 1988 and held several positions within the university until his retirement in 2003. From 1995 to 1999, he was Director of the International Center for Biotechnology. After his retirement, Toshiomi Yoshida was appointed as Director of the Bangkok Liaison Office of the Japan Society for the Promotion of Science, a position he hold until 2007. From 2007 to 2012, he was Director General of the Research Institute of Environmental, Agriculture and Fisheries of the Osaka Prefectural Government. In between 2009 and 2013, Toshiomi Yoshida served as the first President of the Asian Federation of Biotechnology.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e13 June 2017\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-VCH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783527340750\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e656\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e53.6\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311054745740,"sku":"9783527340750","price":221.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783527340750_67018827-3627-4efd-be9a-20ccc7ff85ca.jpg?v=1780618119"},{"product_id":"9780471971177","title":"Modern Strategy for Preclinical Pharmaceutical R\u0026D Towards the Virtual Research Company","description":"\u003ch1\u003eModern Strategy for Preclinical Pharmaceutical R\u0026amp;D\u003c\/h1\u003e\u003ch2\u003eTowards the Virtual Research Company\u003c\/h2\u003e\u003ch3\u003eDavid Cavalla\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pharmacology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eThe twentieth century has been a great success for modern medicine, and has resulted in the generation of a plethora of drugs to treat most common illnesses. However, in the light of increasing regulatory demands, spiralling costs and diminishing commercial returns, the question of how, when, where and whether to conduct pharmaceutical R\u0026amp;D has profound implications, and not just for those within the pharmaceutical industry. In response to these and other dilemmas, the authors define the processes involved in drug research, and examine the advantages and disadvantages of collaborative methods of drug research, and examine the roles that academia, CROs, small \"biotechnology\" companies and \"research boutiques,\" and possibly even the \"virtual research company\" might play as contractors and collaborators.\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eDavid Cavalla\u003c\/b\u003e is an expert on secondary uses for existing drugs, or drug repurposing. He currrently operates through his consultancy, Numedicus Ltd, having worked in drug repurposing for 15 years. Previously he was CEO of Arachnova, and prior to that held various senior positions in pharmaceutical drug discovery at GSK and Napp Research Centre. He has written widely on drug discovery strategy, and is the author of 70 published papers and patents.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e14 October 1997\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471971177\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e231\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e17.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311070834828,"sku":"9780471971177","price":281.65,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471971177_e24793ca-c354-43e0-bf2c-6c8a00174108.jpg?v=1780207604"},{"product_id":"9780470121948","title":"Practical Approaches to Method Validation and Essential Instrument Qualification","description":"\u003ch1\u003ePractical Approaches to Method Validation and Essential Instrument Qualification\u003c\/h1\u003e\u003ch3\u003eChung Chow Chan | Herman Lam | Xue-Ming Zhang\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Analytic\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cb\u003ePractical approaches to ensure that analytical methods and instruments meet GMP standards and requirements\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eComplementing the authors' first book, Analytical Method Validation and Instrument Performance Verification, this new volume provides coverage of more advanced topics, focusing on additional and supplemental methods, instruments, and electronic systems that are used in pharmaceutical, biopharmaceutical, and clinical testing. Readers will gain new and valuable insights that enable them to avoid common pitfalls in order to seamlessly conduct analytical method validation as well as instrument operation qualification and performance verification.\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003ePart 1, Method Validation, begins with an overview of the book's risk-based approach to phase appropriate validation and instrument qualification; it then focuses on the strategies and requirements for early phase drug development, including validation of specific techniques and functions such as process analytical technology, cleaning validation, and validation of laboratory information management systems\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003ePart 2, Instrument Performance Verification, explores the underlying principles and techniques for verifying instrument performance—coverage includes analytical instruments that are increasingly important to the pharmaceutical industry, such as NIR spectrometers and particle size analyzers—and offers readers a variety of alternative approaches for the successful verification of instrument performance based on the needs of their labs\u003c\/p\u003e \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eAt the end of each chapter, the authors examine important practical problems and share their solutions. All the methods covered in this book follow Good Analytical Practices (GAP) to ensure that reliable data are generated in compliance with current Good Manufacturing Practices (cGMP).\u003c\/p\u003e \u003cp\u003eAnalysts, scientists, engineers, technologists, and technical managers should turn to this book to ensure that analytical methods and instruments are accurate and meet GMP standards and requirements.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eCHUNG CHOW CHAN\u003c\/b\u003e, PhD, is a Consultant for CCC Consulting, and the former president of the Calibration \u0026amp; Validation Group, a nonprofit organization dedicated to the art and science of instrument calibration and method validation.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eHERMAN LAM\u003c\/b\u003e, PhD, is the Principal of Wild Crane Horizon and President of the Calibration \u0026amp; Validation Group. Dr. Lam has developed and presented an instrument qualification and performance verification course for Agilent Technologies and other organizations in North America and Asia.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eXUE MING ZHANG\u003c\/b\u003e, PhD, is a Manager at Apotex, responsible for overseeing the development of stable liquid formulations. He also works on method development and validation for both instrument and chemical analysis.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e27 September 2010\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470121948\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e416\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e24.32\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311076798604,"sku":"9780470121948","price":121.46,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470121948.jpg?v=1780207720"},{"product_id":"9783527340545","title":"Pharmaceutical Nanotechnology, 2 Volumes Innovation and Production","description":"\u003ch3\u003eApplications of Nanotechnology\u003c\/h3\u003e\u003ch1\u003ePharmaceutical Nanotechnology, 2 Volumes\u003c\/h1\u003e\u003ch2\u003eInnovation and Production\u003c\/h2\u003e\u003ch3\u003eJean Cornier | Andrew Owen | Arno Kwade | Marcel Van de Voorde\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eTechnology \u0026amp; Engineering \/ Materials Science \/ General\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eDieses Fachbuch legt den Schwerpunkt auf konkrete Methoden und die jüngsten Fortschritte bei der Anwendung von Nanotechnologie für die Entwicklung neuer medikamentöser Therapieansätze und die medizinische Diagnostik. Von den Grundlagen der Nanopharmazie, einschließlich Charakterisierung und Herstellungsverfahren, bis hin zur Rolle von Nanopartikeln und Wirkstoffen wird das Fachgebiet umfassend dargestellt. Anwendungsbeispiele beziehen sich auf Fragestellungen bei der Medikamentenentwicklung und die Übertragung auf die klinische Praxis, Marktchancen und Aspekte der industriellen Vermarktung. Die beschriebenen Anwendungen stammen aus der Behandlung von Krebserkrankungen und weiteren wichtigen Therapiebereichen wie Infektionskrankheiten und Dermatologie. Abgerundet wird das Fachbuch durch eine ausführliche Erörterung sicherheitsrelevanter, rechtlicher und gesellschaftlicher Fragen.\u003cbr\u003e Geschrieben von einem erstklassigen Team von Herausgebern und Autoren, die zu den führenden Experten in Europa und den USA sowie zu den Pionieren der Nanopharmazie gehören.\u003cbr\u003e \u003cbr\u003e\n\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eJean Cornier\u003c\/b\u003e is presently consultant to several companies in the areas of life science, new technologies and business development. He obtained his PhD from the University of Caen, France, and a MSc degree in pharmaceutical medicine from the University of Duisburg-Essen, Germany. Since 1986 he has worked in the space industry as expert in Materials and Life Science research and projects, was participant in space commercialisation initiatives supported by the European and German space agencies as well as in several EU-funded projects in biotechnology and civil security research.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eProfessor Arno Kwade\u003c\/b\u003e is Head of the Center of Pharmaceutical Engineering and of the Institute of Particle Technology at the Technical University Braunschweig, Germany. After his PhD he worked nine years in industry as partner of a consulting firm for processing and handling of materials and as general manager of a medium-sized company active in materials processing. Professor Kwade is speaker of the European working party on comminution and classification and developed a course on nanomilling, taken by more than 1000 participants from different industries, among them many pharmaceutical companies.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eProfessor Andrew Owen\u003c\/b\u003e holds a personal Chair in Molecular and Clinical Pharmacology at the University of Liverpool, UK. He is also affiliated to the MRC Centre for Drug Safety Science and the Wolfson Centre for Personalised Medicine. He is Chair of the British Society for Nanomedicine, is co-inventor of several patents related to nanomedicines and has contributed to over 150 publications and book chapters. He is co-founder of University commercial start-ups, a Fellow of the Royal Society of Biology, a Fellow of the British Pharmacological Society and member of the steering committee for the Academy of Pharmaceutical Sciences Nanomedicine Focus Group.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eMarcel Van de Voorde\u003c\/b\u003e has 40 years' experience in European Research Organisations including CERN-Geneva, European Commission, with 10 years at the Max Planck Institute in Stuttgart, Germany. For many years, he was involved in research and research strategies, policy and management, especially in European research institutions. He holds a Professorship at the University of Technology in Delft, the Netherlands, as well as multiple visiting professorships in Europe and worldwide. He holds a doctor honoris causa and various honorary Professorships.\u003cbr\u003eHe is senator of the European Academy for Sciences and Arts, in Salzburg and Fellow of the World Academy for Sciences. He is a Fellow of various scientific societies and has been decorated by the Belgian King. He has authored of multiple scientific and technical publications and co-edited multiple books in the field of nanoscience and nanotechnology.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e26 June 2017\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-VCH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783527340545\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e775\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e70.4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311099965580,"sku":"9783527340545","price":369.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783527340545_4c4d1ce5-405d-4cb2-82d8-1b660c153b80.jpg?v=1780618768"},{"product_id":"9780470023563","title":"Applied Mixed Models in Medicine","description":"\u003ch3\u003eStatistics in Practice\u003c\/h3\u003e\u003ch1\u003eApplied Mixed Models in Medicine\u003c\/h1\u003e\u003ch3\u003eHelen Brown | Robin Prescott\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMathematics \/ Probability \u0026amp; Statistics \/ General\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eA mixed model allows the incorporation of both fixed and random variables within a statistical analysis. This enables efficient inferences and more information to be gained from the data. The application of mixed models is an increasingly popular way of analysing medical data, particularly in the pharmaceutical industry. There have been many recent advances in mixed modelling, particularly regarding the software and applications. This new edition of a groundbreaking text discusses the latest developments, from updated SAS techniques to the increasingly wide range of applications.  \u003cul\u003e \u003cli\u003ePresents an overview of the theory and applications of mixed models in medical research, including the latest developments and new sections on bioequivalence, cluster randomised trials and missing data.\u003c\/li\u003e \u003cli\u003eEasily accessible to practitioners in any area where mixed models are used, including medical statisticians and economists.\u003c\/li\u003e \u003cli\u003eIncludes numerous examples using real data from medical and health research, and epidemiology, illustrated with SAS code and output.\u003c\/li\u003e \u003cli\u003eFeatures new version of SAS, including the procedure PROC GLIMMIX and an introduction to other available software.\u003c\/li\u003e \u003cli\u003eSupported by a website featuring computer code, data sets, and further material, available at: http:\/\/www.chs.med.ed.ac.uk\/phs\/mixed\/.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThis much-anticipated second edition is ideal for applied statisticians working in medical research and the pharmaceutical industry, as well as teachers and students of statistics courses in mixed models. The text will also be of great value to a broad range of scientists, particularly those working the medical and pharmaceutical areas.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  Helen Brown, Principal Statistician, NHS Scotland, Edinburgh, UK  \u003cp\u003eRobin Prescott, Medical Statistics Unit, University of Edinburgh Medical School, UK\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e25 May 2006\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470023563\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e480\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e31.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311121199244,"sku":"9780470023563","price":132.26,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470023563.jpg?v=1780208064"},{"product_id":"9780471110989","title":"Introduction to Fluorescence Spectroscopy","description":"\u003ch3\u003eTechniques in Analytical Chemistry\u003c\/h3\u003e\u003ch1\u003eIntroduction to Fluorescence Spectroscopy\u003c\/h1\u003e\u003ch3\u003eAshutosh Sharma | Stephen G. Schulman\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Analytic\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eFluoreszenzspektroskopie von Molekülen - physikalische Grundlagen, instrumentelle Ausrüstung, Methoden und Anwendungen - hier bleibt keine Frage unbeantwortet! Das Buch ist für Forscher und Techniker ohne Vorkenntnisse auf diesem Gebiet gedacht, leicht verständlich geschrieben und auf Probleme der analytischen Praxis orientiert. (04\/99)\u003cbr\u003e\n\u003c\/div\u003e\u003cdiv\u003e ASHUTOSH SHARMA is Director of the Institute of Diagnostics and Measurement Instrumentation Technology in the United Kingdom, and also Visiting Professor of Medicinal Chemistry at the University of Florida. STEPHEN G. SCHULMAN is Professor of Medicinal Chemistry at the University of Florida.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e21 May 1999\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Interscience\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471110989\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e192\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e16.64\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311134961804,"sku":"9780471110989","price":170.06,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471110989_ba778025-22e0-4524-824f-264bd1af00ac.jpg?v=1780233767"},{"product_id":"9781405158374","title":"Recent Advances in Polyphenol Research, Volume 1","description":"\u003ch3\u003eRecent Advances in Polyphenol Research\u003c\/h3\u003e\u003ch1\u003eRecent Advances in Polyphenol Research, Volume 1\u003c\/h1\u003e\u003ch3\u003eFouad Daayf | Vincenzo Lattanzio\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Life Sciences \/ Botany\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003ePolyphenols are the second most abundant class of substances in nature, and include tannins and flavonoids, many of which have extremely important antioxidant properties which have now been shown to have a key role in the prevention of cancer in humans. \u003cp\u003eThis important book covers polyphenol chemistry, biosynthesis and genetic manipulation, ecology and plant physiology, food and nutritional aspects and the effects of polyphenols on health. Included within the contents are cutting edge chapters on biotic and abiotic stress in plants, safety and toxicity in foods, functionality and nutraceutical benefits in nutrition, and aspects of pharmaceutical and cosmetic discovery and development.\u003c\/p\u003e \u003cp\u003eSponsored by Groupe Polyphenols, this landmark book has been edited by Professor Fouad Daayf and Professor Vincenzo Lattanzio, who have drawn together an impressive list of internationally respected contributing authors, each providing a comprehensive review of the current situation regarding each important subject covered.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eRecent Advances in Polyphenol Research\u003c\/i\u003e is an important publication which will be of great use to chemists, biochemists, plant scientists, pharmacognosists and pharmacologists, food scientists and nutritionists. Libraries in all universities and research establishments where these subjects are studied and taught should have copies of this book on their shelves.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eProfessor Fouad Daayf\u003c\/b\u003e, Department of Plant Science, University of Manitoba, Canada.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eProfessor Vincenzo Lattanzio\u003c\/b\u003e, Department of Agriscience, Universita degli Studi di Foggia, Italy.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e25 August 2008\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781405158374\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e416\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e37.44\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311160914060,"sku":"9781405158374","price":339.26,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781405158374.jpg?v=1780171566"},{"product_id":"9780470023211","title":"The Chemistry of Organolithium Compounds, Volume 2 R-Li","description":"\u003ch3\u003ePatai's Chemistry of Functional Groups\u003c\/h3\u003e\u003ch1\u003eThe Chemistry of Organolithium Compounds, Volume 2\u003c\/h1\u003e\u003ch2\u003eR-Li\u003c\/h2\u003e\u003ch3\u003eZvi Rappoport | Ilan Marek\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Organic\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cb\u003ePatai Series: The Chemistry of Functional Groups\u003c\/b\u003e \u003cp\u003e\u003ci\u003eA series of advanced treatises founded by Professor Saul Patai and under the general editorship of Professor Zvi Rappoport\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eThe Patai Series publishes comprehensive reviews on all aspects of specific functional groups. Each volume contains outstanding surveys on theoretical and computational aspects, NMR, MS, other spectroscopical methods and analytical chemistry, structural aspects, thermochemistry, photochemistry, synthetic approaches and strategies, synthetic uses and applications in chemical and pharmaceutical industries, biological, biochemical and environmental aspects.\u003c\/p\u003e \u003cp\u003eTo date, over 100 volumes have been published in the series.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eRecently Published Titles\u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eThe chemistry of the Cyclopropyl Group (Volume 2)\u003c\/li\u003e \u003cli\u003eThe chemistry of the Hydrazo Azo and Azozy Groups (Volume 2, 2 parts)\u003c\/li\u003e \u003cli\u003eThe chemistry of Double-Bonded Functional Groups (Volume 3, 2 parts)\u003c\/li\u003e \u003cli\u003eThe chemistry of Organophosphorus Compounds (Volume 4)\u003c\/li\u003e \u003cli\u003eThe chemistry of Halides, Pseudo-Halides and Azides (Volume 2, 2 parts)\u003c\/li\u003e \u003cli\u003eThe chemistry of the Amino, Nitro and Nitroso Groups (2 volumes, 2 parts)\u003c\/li\u003e \u003cli\u003eThe chemistry of Dienes and Polyenes (2 volumes)\u003c\/li\u003e \u003cli\u003eThe chemistry of Organic Derivatives of Gold and Silver\u003c\/li\u003e \u003cli\u003eThe chemistry of Organic Silicon Compounds (2 volumes, 4 parts)\u003c\/li\u003e \u003cli\u003eThe chemistry of Organic Germanium, Tin and Lead Compounds (Volume 2, 2 parts)\u003c\/li\u003e \u003cli\u003eThe chemistry of Phenols (2 parts)\u003c\/li\u003e \u003cli\u003eThe chemistry of Organolithium Compounds (2 parts)\u003c\/li\u003e \u003cli\u003eThe chemistry of Cyclobutanes (2 parts)\u003c\/li\u003e \u003cli\u003eForthcoming Titles\u003c\/li\u003e \u003cli\u003eThe chemistry of Peroxides (Volume 2, 2 parts)\u003c\/li\u003e \u003cli\u003eThe chemistry of Organozinc Compounds\u003c\/li\u003e \u003cli\u003eThe chemistry of Anilines\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003cb\u003eThe Patai Series Online\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe Patai Series is available in electronic format on Wiley InterScience. All new titles will be published online and a growing list of older titles is added every year. It is the ultimate goal that all titles published in the Patai Series will be available in electronic format.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cstrong\u003eProfessor Zvi Rappoport\u003c\/strong\u003e, Department of Organic Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e10 February 2006\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470023211\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e768\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e43.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311162519692,"sku":"9780470023211","price":920.66,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470023211.jpg?v=1780234246"},{"product_id":"9783527329946","title":"Pharmaceutical Biotechnology Drug Discovery and Clinical Applications","description":"\u003ch1\u003ePharmaceutical Biotechnology\u003c\/h1\u003e\u003ch2\u003eDrug Discovery and Clinical Applications\u003c\/h2\u003e\u003ch3\u003eOliver Kayser | Heribert Warzecha\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Biotechnology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eThis second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmaceutical research, written by a team of industry experts from around the world, while quality and safety management, drug approval and regulation, patenting issues, and biotechnology fundamentals are also covered. In addition, this new edition now not only includes biotech drug development but also the use of biopharmaceuticals in diagnostics and vaccinations. \u003cbr\u003e With a foreword by Robert Langer, Kenneth J Germeshausen Professor of Chemical and Biomedical Engineering at MIT and member of the National Academy of Engineering and the National Academy of Sciences.\u003c\/div\u003e\u003cdiv\u003e Oliver Kayser: Oliver Kayser received his PhD at the Free University Berlin in 1997 following his fellowship at the University of Gainesville, Florida, whereupon he entered the pharmaceutical biotechnology industry. He is currently a lecturer at the Department of Pharmaceutics, Biopharmacy and Biotechnology at the FU Berlin, working on new biotech drugs from natural sources and on the development of drug delivery carriers based on nanosuspension and solid lipid nanoparticle enterprise technologies. \u003cbr\u003e \u003cbr\u003e \u003cbr\u003e Prof. Dr. Heribert Warzecha \u003cbr\u003e Studied Pharmazie at the Johannes Gutenberg-Universitat, Mainz. After completing his Ph.D. in 1998, he worked first as a postdoctoral fellow at Cornell, USA, and become associate Professor in wurzburg in 2001. Since 2007 he is full Professor at the technical university of Darmstadt and became dean of the Institute of plant science in 2009. \u003cbr\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e29 May 2012\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783527329946\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e676\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e50.08\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311254106252,"sku":"9783527329946","price":290.7,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783527329946_7c8b0834-e730-4a5c-a2e7-e0b92e315a54.jpg?v=1780618089"},{"product_id":"9780471771517","title":"RNA Interference Application to Drug Discovery and Challenges to Pharmaceutical Development","description":"\u003ch1\u003eRNA Interference\u003c\/h1\u003e\u003ch2\u003eApplication to Drug Discovery and Challenges to Pharmaceutical Development\u003c\/h2\u003e\u003ch3\u003ePaul H. Johnson | John J. Rossi\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pharmacology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003ci\u003eRNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development\u003c\/i\u003e provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. The first part covers more general background of RNA interference and its application in drug discovery. In the second part, the book addresses siRNA (small interfering RNA), a pharmaceutically potent form, and its use and delivery in therapeutics along with manufacturing and delivery aspects.\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003ePAUL H. JOHNSON, PhD\u003c\/b\u003e, is a cofounder and Chief Scientific Officer at PhaseRx, Inc. He is the author of numerous scientific papers and patents, and was the recipient of the 2007 Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e15 February 2011\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471771517\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e340\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e20.8\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311265443980,"sku":"9780471771517","price":144.85,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471771517_5655cc9f-6747-44d5-bc61-654204c3cbd1.jpg?v=1780175042"},{"product_id":"9780470145593","title":"Molecular Pathology in Drug Discovery and Development","description":"\u003ch1\u003eMolecular Pathology in Drug Discovery and Development\u003c\/h1\u003e\u003ch3\u003eJ. Suso Platero\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pharmacology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003eCovers powerful new tools for drug development\u003c\/p\u003e \u003cp\u003eMolecular pathology offers tools and techniques that can greatly enhance the drug discovery and development process, helping to make the promises of personalized medicine a reality. Molecular Pathology in Drug Discovery and Development provides an unmatched guide to this cutting-edge discipline and its applications to pharmaceutical science.\u003c\/p\u003e \u003cp\u003eWith contributions from leading lights in drug discovery, drug development, and molecular pathology balanced by a consistent editorial approach, this reference offers both an overview of molecular pathology and a close look at the methods as they are applied to the process of drug discovery and development. Presented as steps in the drug development process, the coverage includes the use of molecular pathology to:\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003eIdentify and validate new drug candidates\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eEnhance transcriptional profiling to better find and validate biomarkers\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eAssess toxicology\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eEmploy toxicogenomics to identify genes relevant to the safety of compounds\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eIdentify correct doses for different drugs\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eIdentify patients for treatment\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eDevelop molecular therapies\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eFurther the new techniques of Immunohistochemistry and Immunofluorescence\u003c\/p\u003e \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eWith many tests and treatments already working today, drug research and development using molecular pathology has shown itself an extremely fruitful area. Molecular Pathology in Drug Discovery and Development gives practitioners an up-to-date resource on this highly active discipline and its role in furthering pharmaceutical research.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003eJ. Suso Platero is Director of Oncology Biomarkers at Centocor. Formerly, he was associate director of  molecular pathology at Bristol-Myers Squibb. Dr. Platero has more than ten years of experience in the discovery, development, and validation of assays for clinical purposes.\u003c\/p\u003e \u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e17 August 2009\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470145593\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e400\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e24.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311297589388,"sku":"9780470145593","price":154.76,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470145593_72c89fbe-d10b-4c81-806b-16a477788b3f.jpg?v=1780205215"},{"product_id":"9783527305827","title":"Agglomeration in Industry, 2 Volume Set: Occurrence and Applications","description":"\u003ch1\u003eAgglomeration in Industry, 2 Volume Set: Occurrence and Applications\u003c\/h1\u003e \u003ch2\u003ePietsch, Wolfgang B.\u003c\/h2\u003e \u003cp\u003eAn up-to-date overview dealing with the occurrence and key applications of agglomeration, including unwanted adhesion and beneficial size enlargement in pharmaceutical, food and animal feed, chemical, fertilizer and agrochemical, mineral, building material and ceramic, metal, solid fuel, as well as other industries. Furthermore, the book emphasizes recent developments at the level of single particles and applications of agglomeration phenomena in nanotechnology.\u003cbr\u003e \u003cbr\u003e The author has a vast academic and industrial experience as researcher, teacher, developer, designer, vendor, and user. He is an expert and consultant in the field of agglomeration, its technologies and products. This background makes the detailed evaluation of the subject possible. Wolfgang Pietsch has held a number of leading positions in both US and German companies and is a frequent speaker at conferences and seminars. He has already written three earlier books on agglomeration.\u003cbr\u003e \u003cbr\u003e Intended for everybody working in companies that process and handle particulate solids, this book helps in understanding and controlling unwanted agglomeration as well as promoting the application, development, and improvement of methods for the beneficial use of agglomeration.\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Wiley-VCH\u003c\/p\u003e \u003cp\u003ePublication Date: 2005-01-04\u003c\/p\u003e \u003cp\u003eFormat: Hardcover\u003c\/p\u003e \u003cp\u003eISBN-13: 9783527305827\u003c\/p\u003e \u003cp\u003eDOI: \u003c\/p\u003e \u003cp\u003eDimensions: 251.50cm x185.40cm\u003c\/p\u003e \u003cp\u003ePages: 834\u003c\/p\u003e ","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311316005004,"sku":"9783527305827","price":508.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783527305827_2927b7fd-0364-4161-b51a-182b9652fe33.jpg?v=1775666953"},{"product_id":"9781119529231","title":"Laboratory Control System Operations in a GMP Environment","description":"\u003ch1\u003eLaboratory Control System Operations in a GMP Environment\u003c\/h1\u003e\u003ch3\u003eDavid M. Bliesner\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Analytic\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cb\u003eDevelop an understanding of FDA and global regulatory agency requirements for Laboratory Control System (LCS) operations\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIn \u003ci\u003eLaboratory Control System Operations in a GMP Environment\u003c\/i\u003e, readers are given the guidance they need to implement a CGMP compliant Laboratory Control System (LCS) that fits within Global Regulatory guidelines. Using the Quality Systems Approach, regulatory agencies like the FDA and the European Medicine Agency have developed a scheme of systems for auditing pharmaceutical manufacturing facilities which includes evaluating the LCS. In this guide, readers learn the fundamental rules for operating a CGMP compliant Laboratory Control System.\u003c\/p\u003e \u003cp\u003eDesigned to help leaders meet regulatory standards and operate more efficiently, the text includes chapters that cover Laboratory Equipment Qualification and Calibration, Laboratory Facilities, Method Validation and Method Transfer, Laboratory Computer Systems, Laboratory Investigations as well as Data Governance and Data Integrity. The text also includes chapters related to Laboratory Managerial and Administrative Systems, Laboratory Documentation Practices and Standard Operating Procedures and General Laboratory Compliance Practices.  Additionally, a chapter outlining Stability Program operations is included in the text.\u003c\/p\u003e \u003cp\u003eIn addition to these topics, it includes LCS information and tools such as:\u003c\/p\u003e \u003cp\u003e●      End of chapter templates, checklists, and LCS guidance to help you follow the required standards\u003c\/p\u003e \u003cp\u003e●      Electronic versions of each tool so users can use them outside of the text\u003c\/p\u003e \u003cp\u003e●      An In-depth understanding of what is required by the FDA and other globally significant regulatory authorities for GMP compliant systems\u003c\/p\u003e \u003cp\u003eFor quality assurance professionals working within the pharmaceutical or biopharma industries, this text provides the insight and tools necessary to implement government-defined regulations.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cb\u003eDAVID M. BLIESNER, Ph.D.,\u003c\/b\u003e is Founder and President of Delphi Analytical Services, Inc. He provides CGMP consulting and training services to the pharmaceutical, biopharmaceutical, contract analytical laboratory, and allied industries. He possesses a unique combination of science and business skills and experience. These skills and experiences range from analytical R\u0026amp;D in the pharmaceutical industry to business plan preparation and market analysis in the chromatography supplies and contract analytical and instrument services businesses. Dr. Bliesner' s expertise includes quality assurance auditing of GMP laboratories, developing and implementing corrective action plans for analytical laboratories with compliance challenges, high performance liquid chromatography, experimental protocol design and project management. He has been part of the \"Expert Consultant\" contingent for five companies operating under consent decree with the FDA where he has helped with the establishment of GMP compliant laboratory control systems. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e03 June 2020\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781119529231\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e320\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e16.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311370694796,"sku":"9781119529231","price":150.26,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781119529231_ed48d4e0-deb3-4851-baee-d9c2543f7ddd.jpg?v=1780140497"},{"product_id":"9780471457145","title":"Industrial Proteomics Applications for Biotechnology and Pharmaceuticals","description":"\u003ch3\u003eMethods of Biochemical Analysis\u003c\/h3\u003e\u003ch1\u003eIndustrial Proteomics\u003c\/h1\u003e\u003ch2\u003eApplications for Biotechnology and Pharmaceuticals\u003c\/h2\u003e\u003ch3\u003eDaniel Figeys\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Life Sciences \/ Biochemistry\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eThis book covers both basic elements and the state-of-the-art in applications of proteomics. The first section gives an introduction to the field, from differential approaches to functional proteomics, including yeast two-hybrid, mass spectrometry, mapping of post-translational modifications, and NMR spectroscopy. The second section offers a complete picture of industry studies in proteomics for human health and biotechnology applications. The final section addresses the future, looking at the most promising areas such as protein arrays and the integration of genomic and proteomic tools.\u003c\/div\u003e\u003cdiv\u003e DANIEL FIGEYS, Ph.D., is the Director of the Ottowa Institute of Systems Biology. Prior to joining the institute, Dr. Figeys was senior vice president, systems biology at MDS Proteomics and a research officer at the NRC-Canada. He did his postdoc at the Department of Molecular Biotechnology in Seattle with Dr. R. Aebersold. \u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e10 February 2005\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Liss\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471457145\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e324\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e16.22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311398613132,"sku":"9780471457145","price":161.06,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471457145_9f976d6b-5058-4f62-b2b4-0b7fe4a60c54.jpg?v=1780101374"},{"product_id":"9780471981213","title":"Chirality in Agrochemicals","description":"\u003ch3\u003eWiley Series in Agrochemicals \u0026amp; Plant Protection\u003c\/h3\u003e\u003ch1\u003eChirality in Agrochemicals\u003c\/h1\u003e\u003ch3\u003eNorio Kurihara | Junshi Miyamoto\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eTechnology \u0026amp; Engineering \/ Agriculture \/ General\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eBisher gab es kein Buch, das sich speziell mit der Chiralität von Agrochemikalien beschäftigte, obwohl dieses Gebiet zunehmende Beachtung in der Industrie findet. Diese Darstellung der Chiralität bei Insektiziden, Fungiziden, Herbiziden und anderen Klassen von Agrochemikalien schließt diese Lücke. Synthese, Analytik, biologische Aktivität, Wirkprinzip, Toxikologie, Metabolismus und Umweltschicksal jeder besprochenen Verbindung werden diskutiert. (8\/98)\u003cbr\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003eNorio Kurihara and Junshi Miyamoto are the authors of Chirality in Agrochemicals , published by Wiley. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e27 October 1998\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471981213\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e288\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e20.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44311507599500,"sku":"9780471981213","price":429.26,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471981213_6a3fd76e-1ad9-4cf6-9836-61dfbf61c63e.jpg?v=1780106047"},{"product_id":"9780471496533","title":"Cross-over Trials in Clinical Research","description":"\u003ch3\u003eStatistics in Practice\u003c\/h3\u003e\u003ch1\u003eCross-over Trials in Clinical Research\u003c\/h1\u003e\u003ch3\u003eStephen S. Senn\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMathematics \/ Probability \u0026amp; Statistics \/ General\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eCross-over trials are an important class of design used in the pharmaceutical industry and medical research, and their use continues to grow. Cross-over Trials in Clinical Research, Second Edition has been fully updated to include the latest methodology used in the design and analysis of cross-over trials. It includes more background material, greater coverage of important statistical techniques, including Bayesian methods, and discussion of analysis using a number of statistical software packages.\u003cbr\u003e * Comprehensive coverage of the design and analysis of cross-over trials.\u003cbr\u003e \u003cbr\u003e * Each technique is carefully explained and the mathematics is kept to a minimum.\u003cbr\u003e \u003cbr\u003e * Features many real and original examples, taken from the author's vast experience.\u003cbr\u003e \u003cbr\u003e * Includes discussion of analysis using SAS, S-Plus and, GenStat, StatXact and Excel.\u003cbr\u003e \u003cbr\u003e * Written in a style suitable for statisticians and physicians alike.\u003cbr\u003e Primarily aimed at statisticians and researchers working in the pharmaceutical industry, the book will also appeal to physicians involved in clinical research and students of medical statistics.\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003eStephen Senn\u003c\/b\u003e has worked for the NHS in England, as a lecturer in Scotland and in drug development in Switzerland (with CIBA-Geigy). Until recently he was Professor of Pharmaceutical and Health Statistics at University College London but since September 2003 he has been  Professor of Statistics at Glasgow University. His books, \u003ci\u003eCross-over Trials in Clinical Research\u003c\/i\u003e (1993, 2nd edition 2002) and \u003ci\u003eStatistical Issues in Drug Development\u003c\/i\u003e (1997) are published by Wiley and his latest book, \u003ci\u003eDicing with Death\u003c\/i\u003e (2003) by Cambridge University Press. In 2001, he was the first recipient of the George C Challis award for biostatistics of the University of Florida. He is a member of the editorial boards of \u003ci\u003eStatistics in Medicine\u003c\/i\u003e, \u003ci\u003eStatistical Methods in Medical Research\u003c\/i\u003e, \u003ci\u003ePharmaceutical Statistics\u003c\/i\u003e and \u003ci\u003eApplied Clinical Trials\u003c\/i\u003e and is a section editor for the Wiley \u003ci\u003eStatistics in Practice\u003c\/i\u003e series.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e09 September 2002\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471496533\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e364\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e25.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44312734335116,"sku":"9780471496533","price":147.56,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471496533_7d167d8e-638b-4861-9f33-5298e951854a.jpg?v=1780157194"},{"product_id":"9780471628828","title":"Medical Botany Plants Affecting Human Health","description":"\u003ch1\u003eMedical Botany\u003c\/h1\u003e\u003ch2\u003ePlants Affecting Human Health\u003c\/h2\u003e\u003ch3\u003eWalter H. Lewis | Memory P. F. Elvin-Lewis\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Alternative \u0026amp; Complementary Medicine\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\u003cul\u003e \u003cli\u003eOrganized by body system and ailment makes it easy to locate appropriate therapies.\u003c\/li\u003e \u003cli\u003eIncludes background on the physiology of major systems and ailments so readers can understand how and why a pharmaceutical, botanical, or dietary supplement works.\u003c\/li\u003e \u003cli\u003eBroad coverage includes green plants, fungi, and microorganisms.\u003c\/li\u003e \u003cli\u003eIncludes extensive references and citations from both conventional and complimentary-alternative medical systems when natural products or their derivatives are involved.\u003c\/li\u003e \u003c\/ul\u003e\u003c\/div\u003e\u003cdiv\u003e WALTER H. LEWIS, PhD, DSc, is Professor Emeritus of Biology and University Research Ethnobotanist at Washington University in St. Louis, Missouri. He is also Senior Botanist at the Missouri Botanical Garden.\u003cbr\u003e MEMORY P. F. ELVIN-LEWIS, PhD, DSc, is Professor of Biomedicine in Microbiology and Ethnobotany, and Adjunct Professor of Biology at Washington University in St. Louis, Missouri.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e04 September 2003\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471628828\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e832\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e44.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44312938578060,"sku":"9780471628828","price":155.66,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471628828_799cbf5b-bad5-4229-b3cf-0cc7002211a6.jpg?v=1780163303"},{"product_id":"9780787963880","title":"Customer Loyalty How to Earn It, How to Keep It","description":"\u003ch1\u003eCustomer Loyalty\u003c\/h1\u003e\u003ch2\u003eHow to Earn It, How to Keep It\u003c\/h2\u003e\u003ch3\u003eJill Griffin | Robert T. Herres\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eBusiness \u0026amp; Economics \/ Customer Relations\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eYou've read about Customer Loyalty in the Los Angeles Times, Dallas Morning News, Miami Herald, Kansas City Star, Entrepreneur, Industry Week, Marketing News, Boardroom Reports, Marketing Management, Library Journal, The Selling Advantage, Ideas Magazine, Executive Briefings, Training, Hospitality Upgrade, Direct, Quality Digest, Marketing Tools, Houseware Executive, Journal of Pharmaceutical Management, Discount Merchandiser, TeleProfessional, NationsBank Business, Modern Jeweler, Furniture Today-- now read the new and revised edition of the ground-breaking book that created all the buzz.\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003eJill Griffin\u003c\/b\u003e is an internationally published author, business consultant, and speaker. As president of the Griffin Group in Austin, Texas, she speaks to and consults with businesses of all sizes, from Fortune 500 companies to law firms and small banks. She is coauthor of \u003ci\u003eCustomer WinBack\u003c\/i\u003e (Jossey-Bass), deemed one of the thirty best business books of 2002 by Soundview Executive Book Summaries.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e09 October 2002\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eJossey-Bass\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780787963880\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e272\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e12.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44312945000588,"sku":"9780787963880","price":20.66,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780787963880.jpg?v=1780160185"},{"product_id":"9780470390092","title":"Carbon-Centered Free Radicals and Radical Cations Structure, Reactivity, and Dynamics","description":"\u003ch3\u003eWiley Series of Reactive Intermediates in Chemistry and Biology\u003c\/h3\u003e\u003ch1\u003eCarbon-Centered Free Radicals and Radical Cations\u003c\/h1\u003e\u003ch2\u003eStructure, Reactivity, and Dynamics\u003c\/h2\u003e\u003ch3\u003eMalcolm D. Forbes\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Organic\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003eCovers the most advanced computational and experimental methods for studying carbon-centered radical intermediates\u003c\/p\u003e \u003cp\u003eWith its focus on the chemistry of carbon-centered radicals and radical cations, this book helps readers fully exploit the synthetic utility of these intermediates in order to prepare fine chemicals and pharmaceutical products. Moreover, it helps readers better understand their role in complex atmospheric reactions and biological systems. Thoroughly up to date, the book highlights the most advanced computational and experimental methods available for studying and using these critically important intermediates.\u003c\/p\u003e \u003cp\u003eCarbon-Centered Free Radicals and Radical Cations begins with a short history of the field of free radical chemistry, and then covers:\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003eA discussion of the relevant theory\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eMechanistic chemistry, with an emphasis on synthetic utility\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eMolecular structure and mechanism, focusing on computational methods\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eSpectroscopic investigations of radical structure and kinetics, including demonstrations of spin chemistry techniques such as CIDNP and magnetic field effects\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eFree radical chemistry in macromolecules\u003c\/p\u003e \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eEach chapter, written by one or more leading experts, explains difficult concepts clearly and concisely, with references to facilitate further investigation of individual topics. The authors were selected in order to provide insight into a broad range of topics, including small molecule synthesis, polymer degradation, computational chemistry as well as highly detailed experimental work in the solid, liquid, and gaseous states.\u003c\/p\u003e \u003cp\u003eThis volume is essential for students or researchers interested in building their understanding of the role of carbon-centered radical intermediates in complex systems and how they may be used to develop a broad range of useful products.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003eMALCOLM D. E. FORBES, PhD, is Professor of Chemistry at the University of North Carolina at Chapel Hill, where he has served in various capacities since 1990.  Professor Forbes's group is involved in free radical research and electron paramagnetic resonance spectroscopy.  He is a renowned educator and lecturer and has received numerous awards for his research and teaching methods, including the Sir Harold Thomson Award from Elsevier, a Japan Society for the Promotion of Science Foreign Fellowship Award, a National Science Foundation Young Investigator Award, and the Bernard Smaller Prize for Research in Magnetic Resonance.  In 2008, he was a J. W. Fulbright Senior Scholar, living and working in Novosibirsk, Russia.\u003c\/p\u003e \u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e08 February 2010\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470390092\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e392\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e24.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44312955846796,"sku":"9780470390092","price":166.46,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470390092_700f3886-d335-4fad-b4ec-718a170930a6.jpg?v=1780165887"},{"product_id":"9780471496373","title":"Pharmaceutical Chemistry Therapeutic Aspects of Biomacromolecules","description":"\u003ch1\u003ePharmaceutical Chemistry\u003c\/h1\u003e\u003ch2\u003eTherapeutic Aspects of Biomacromolecules\u003c\/h2\u003e\u003ch3\u003eChristine Bladon\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Industrial \u0026amp; Technical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e- umfassende Einführung in das schnell wachsende Gebiet der pharmazeutischen Chemie\u003cbr\u003e - Angaben zur therapeutischen Nutzung von Peptiden, Proteinen, Nucleinsäuren und Kohlenhydraten\u003cbr\u003e - mit zahlreichen Abbildungen\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cstrong\u003eChristine Bladon\u003c\/strong\u003e is the author of \u003cem\u003ePharmaceutical Chemistry: Therapeutic Aspects of Biomacromolecules \u003c\/em\u003e, published by Wiley. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e10 April 2002\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471496373\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e240\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e14.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44312966725772,"sku":"9780471496373","price":107.96,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471496373_9e37c0df-2b27-4251-b5db-20cd3ceb2d3d.jpg?v=1780145788"},{"product_id":"9780471496366","title":"Pharmaceutical Chemistry Therapeutic Aspects of Biomacromolecules","description":"\u003ch1\u003ePharmaceutical Chemistry\u003c\/h1\u003e\u003ch2\u003eTherapeutic Aspects of Biomacromolecules\u003c\/h2\u003e\u003ch3\u003eChristine Bladon\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Industrial \u0026amp; Technical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e- umfassende Einführung in das schnell wachsende Gebiet der pharmazeutischen Chemie\u003cbr\u003e - Angaben zur therapeutischen Nutzung von Peptiden, Proteinen, Nucleinsäuren und Kohlenhydraten\u003cbr\u003e - mit zahlreichen Abbildungen\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003eChristine Bladon is the author of Pharmaceutical Chemistry: Therapeutic Aspects of Biomacromolecules , published by Wiley. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e10 April 2002\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471496366\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e234\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e20.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44312966856844,"sku":"9780471496366","price":270.86,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471496366_76dc803f-a296-4782-84dd-315feb148d60.jpg?v=1780162548"},{"product_id":"9780471496496","title":"On-line LC-NMR and Related Techniques","description":"\u003ch1\u003eOn-line LC-NMR and Related Techniques\u003c\/h1\u003e\u003ch3\u003eKlaus Albert\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Analytic\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eDie Kopplung der NMR mit Stofftrennverfahren, insbesondere chromatographischen Methoden, gehört inzwischen zu den wichtigsten Ansätzen der analytischen Chemie. Dieser experimentell orientierte Band, verfaßt von Herstellern von LC-NMR-Ausrüstung, macht Sie mit dem modernsten Stand der Technik und ihrer Anwendung auf spezielle Probleme vertraut.\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eKlaus Albert\u003c\/b\u003e is the editor of \u003ci\u003eOn-line LC-NMR and Related Techniques\u003c\/i\u003e, published by Wiley.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e09 September 2002\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471496496\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e274\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e20.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44312997855372,"sku":"9780471496496","price":270.86,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471496496_abdfedab-11d2-43fe-8b88-449bd4d240e0.jpg?v=1780165334"},{"product_id":"9783527299959","title":"Industrial Pharmaceutical Biotechnology","description":"\u003ch1\u003eIndustrial Pharmaceutical Biotechnology\u003c\/h1\u003e\u003ch3\u003eHeinrich Klefenz\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Industrial \u0026amp; Technical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eDieses Buch beschreibt die pharmazeutische Biotechnologie als zentrales Gebiet der Life Sciences. Das komplette Spektrum an Konzepten, Verfahren und Technologien der Biotechnologie wird heute auch in der pharmazeutischen Forschung, Entwicklung und der Herstellung von Arzneimitteln angewandt. Die Ergebnisse der Genom-Sequenzierung und die Erforschung der biologischen Funktion von Genen werden mit chemischer Technologie, Mikroelektonik und Mikrosystemtechnologie kombiniert, um Biochips als Diagnostica herzustellen. Ungezählte biologische Stukturen werden durch neue ergänzt, die durch neu angeordnete Gen-Cluster und biokatalytische Verfahren gewonnen werden. Neue Organisationsstrukturen von Instituten, Firmen und Netzwerken ermöglichen es, dass Forschungserkenntnisse viel schneller als bisher Eingang in die industrielle Praxis finden.\u003cbr\u003e \u003cbr\u003e Ein Buch für alle Biotechnologen, die sich mit Forschung, Entwicklung und Herstellung von Arzneimitteln befassen, ebenso wie für Entscheidungsträger in Biotechnologie-, Pharma- und Chemiefirmen und Forschungseinrichtungen sowie die Gründer von Biotechunternehmen und für Kapitalgesellschaften.\u003cbr\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003eHeinrich Klefenz is the author of Industrial Pharmaceutical Biotechnology, published by Wiley. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e22 April 2002\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-VCH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783527299959\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e393\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e25.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44314190577804,"sku":"9783527299959","price":274.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783527299959_fa0ad1e1-904c-4e32-b26e-af5db57ef0ae.jpg?v=1780200785"},{"product_id":"9783527334612","title":"De novo Molecular Design","description":"\u003ch1\u003eDe novo Molecular Design\u003c\/h1\u003e\u003ch2\u003e\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eContributors:\u003c\/strong\u003e Schneider, Gisbert\u003c\/p\u003e\u003cp\u003eSystematically examining current methods and strategies, this ready reference covers a wide range of molecular structures, from organic-chemical drugs to peptides, Proteins and nucleic acids, in line with emerging new drug classes derived from biomacromolecules.\u003cbr\u003e \u003cbr\u003e A leader in the field and one of the pioneers of this young discipline has assembled here the most prominent experts from across the world to provide first-hand knowledge. While most of their methods and examples come from the area of pharmaceutical discovery and development, the approaches are equally applicable for chemical probes and diagnostics, pesticides, and any other molecule designed to interact with a biological system. Numerous images and screenshots illustrate the many examples and method descriptions.\u003cbr\u003e \u003cbr\u003e With its broad and balanced coverage, this will be the firststop resource not only for medicinal chemists, biochemists and biotechnologists, but equally for bioinformaticians and molecular designers for many years to come.\u003cbr\u003e \u003cbr\u003e \u003cbr\u003e From the content:\u003cbr\u003e \u003cbr\u003e * Reaction-driven de novo design\u003cbr\u003e * Adaptive methods in molecular design\u003cbr\u003e * Design of ligands against multitarget profiles\u003cbr\u003e * Free energy methods in ligand design\u003cbr\u003e * Fragment-based de novo design\u003cbr\u003e * Automated design of focused and target family-oriented compound libraries\u003cbr\u003e * Molecular de novo design by nature-inspired computing\u003cbr\u003e * 3D QSAR approaches to de novo drug design\u003cbr\u003e * Bioisosteres in de novo design\u003cbr\u003e * De novo design of peptides, proteins and nucleic acid structures, including RNA aptamers\u003cbr\u003e \u003cbr\u003e and many more.\u003cbr\u003e\u003c\/p\u003e\u003ch3\u003eBook Details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePublisher:\u003c\/strong\u003e Wiley-VCH\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e 2013-12-23\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e Hardcover\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eISBN-13:\u003c\/strong\u003e 9783527334612\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePages:\u003c\/strong\u003e 576\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Wiley-VCH","offers":[{"title":"Default Title","offer_id":44314241499276,"sku":"9783527334612","price":179.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783527334612_c0628fd1-ed13-48c1-9fae-99b62543608f.jpg?v=1768916940"},{"product_id":"9780470253175","title":"Oral Controlled Release Formulation Design and Drug Delivery Theory to Practice","description":"\u003ch1\u003eOral Controlled Release Formulation Design and Drug Delivery\u003c\/h1\u003e\u003ch2\u003eTheory to Practice\u003c\/h2\u003e\u003ch3\u003eHong Wen | Kinam Park\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Organic\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eThis book describes the theories, applications, and challenges for different oral controlled release formulations. This book differs from most in its focus on oral controlled release formulation design and process development. It also covers the related areas like preformulation, biopharmaceutics, in vitro-in vivo correlations (IVIVC), quality by design (QbD), and regulatory issues.\u003c\/div\u003e\u003cdiv\u003e  \u003cb\u003eHONG WEN, PhD,\u003c\/b\u003e is a Fellow and Project Leader in the Department of Pharmaceutical Development at Novartis, as well as a core member of the Novartis TRD S\u0026amp;T committee. He has contributed to dozens of INDs\/IMPDs in addition to several approved NDAs. His expertise spans from discovery support and preformulation to late-phase development of solid dosage forms. He also specializes in bioavailability enhancement for water insoluble drugs, oral sustained release (SR) formulations, and combination products (FDC). He has written fifteen publications, six presentations, and eight patents in the drug delivery and controlled release fields.  \u003cp\u003e\u003cb\u003eKINAM PARK, PhD,\u003c\/b\u003e is a Professor in the Department of Pharmaceutics and Showalter Distinguished Professor of Biomedical Engineering at Purdue University. He is also the President of Akina, Inc., specializing in drug delivery. Dr. Park is Editor-in-Chief of the \u003ci\u003eJournal of Controlled Release\u003c\/i\u003e among other journal and advisory board appointments. The recipient of the Controlled Release Society Founders Award in 2004, Dr. Park has published nine books, more than a hundred chapters, and more than two hundred journal articles, and holds sixteen patents.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e19 October 2010\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470253175\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e384\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e37.6\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44314299170956,"sku":"9780470253175","price":137.66,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470253175_2950bfd4-a452-4778-a9a1-2ae1c907b892.jpg?v=1780618453"},{"product_id":"9780471213918","title":"Pharmaceutical Manufacturing Handbook, 2 Volume Set","description":"\u003ch3\u003ePharmaceutical Development Series\u003c\/h3\u003e\u003ch1\u003ePharmaceutical Manufacturing Handbook, 2 Volume Set\u003c\/h1\u003e\u003ch3\u003eShayne Cox Gad\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Industrial \u0026amp; Technical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003ci\u003ePharmaceutical Manufacturing Handbook\u003c\/i\u003e covers a range of topics to help professionals better understand the methods used in the pharmaceutical manufacturing, pharmaceutical engineering, and process engineering fields. It covers many aspects, such as the building of a facility, to the various dosage and delivery forms available, and finally to the principles of validation. Other topics include quality assurance and regulatory requirements. Without exposure to all of these topics, professionals and others in the various pharmaceutical fields will not be able to produce quality drugs.\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003eSHAYNE COX GAD, PhD, DABT, ATS,\u003c\/b\u003e is the Principal of Gad Consulting Services. Dr. Gad has more than thirty years of experience as a toxicologist, statistical consultant, manager, and general consultant on research and development in the chemical, consumer product, contract testing, biotechnology, medical device, and pharmaceutical industries. He is the author of twenty-nine books and numerous papers, presentations, and other publications.\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e28 March 2008\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Interscience\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471213918\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e2240\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e130.56\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44314362544268,"sku":"9780471213918","price":368.96,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471213918_2b4ffe5b-4168-4418-93e9-3f210f3f760a.jpg?v=1780157390"},{"product_id":"9780471213833","title":"Preclinical Development Handbook, 2 Volume Set","description":"\u003ch3\u003ePharmaceutical Development Series\u003c\/h3\u003e\u003ch1\u003ePreclinical Development Handbook, 2 Volume Set\u003c\/h1\u003e\u003ch3\u003eShayne Cox Gad\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pharmacology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eGegliedert in die Bände \"Biopharmaceutical Properties\" und \"Toxicology\", informiert das Werk gründlich zu allen Fragen der vorklinischen Arzneimittelentwicklung. Auftretende Probleme und Lösungsmöglichkeiten werden ebenso aufgezeigt wie Methoden zur Qualitätssicherung.\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cstrong\u003eShayne Cox Gad\u003c\/strong\u003e, PHD, DABT, ATS, is the Principal of Gad Consulting Services. He has more than thirty years of experience as a toxicologist, statistical consultant, manager, and consultant on research and development in the chemical, consumer product, contract testing, biotechnology, medical device, and pharmaceutical industries. He is the author of twenty-nine books and numerous papers, presentations, and other publications. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e14 March 2008\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Interscience\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780471213833\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e2432\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e63.84\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44314395803788,"sku":"9780471213833","price":368.96,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780471213833_9c978f3f-d1df-4e0b-b6b5-9fe377f0fff2.jpg?v=1780162104"},{"product_id":"9780470938430","title":"Biophysical Methods for Biotherapeutics Discovery and Development Applications","description":"\u003ch1\u003eBiophysical Methods for Biotherapeutics\u003c\/h1\u003e\u003ch2\u003eDiscovery and Development Applications\u003c\/h2\u003e\u003ch3\u003eTapan K. Das\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pharmacology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003eWith a focus on practical applications of biophysical techniques, this book links fundamental biophysics to the process of biopharmaceutical development.\u003c\/p\u003e \u003cp\u003e• Helps formulation and analytical scientists in pharma and biotech better understand and use biophysical methods\u003cbr\u003e • Chapters organized according to the sequential nature of the drug development process\u003cbr\u003e • Helps formulation, analytical, and bioanalytical scientists in pharma and biotech better understand and usestrengths and limitations of biophysical methods\u003cbr\u003e • Explains how to use biophysical methods, the information obtained, and what needs to be presented in a regulatory filing, assess impact on quality and immunogenicity\u003cbr\u003e • With a focus on practical applications of biophysical techniques, this book links fundamental biophysics to the process of biopharmaceutical development.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cb\u003eTAPAN K. DAS\u003c\/b\u003e is the Director of the Mass Spectrometry and Biophysics Center of Excellence in the Analytical Development and Testing group at Bristol-Myers Squibb. He is responsible for biophysical and analytical development for biotherapeutics structure-function characterization, analytical comparability, protein particulate analysis, and support for commercial biotherapeutics products. Dr. Das is also the Chair of the Biotechnology Section of Ameri an Association of Pharmaceutical Scientists. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e28 April 2014\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470938430\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e376\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e22.88\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44314399146124,"sku":"9780470938430","price":134.06,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470938430.jpg?v=1780162712"},{"product_id":"9781405178235","title":"Pain Management Expanding the Pharmacological Options","description":"\u003ch1\u003ePain Management\u003c\/h1\u003e\u003ch2\u003eExpanding the Pharmacological Options\u003c\/h2\u003e\u003ch3\u003eGary J. McCleane\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Nursing \/ Anesthesia\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eConventional pharmaceutical approaches to pain management are not always successful. Using only those medications that have an official indication for a certain condition \u003ci\u003ereduces substantially the chance of the patient gaining pain relief and may expose them to intolerable side effects\u003c\/i\u003e. However evidence now exists on the use of other drugs, produced for non-pain conditions, and how they can substantially increase the chances of pain relief.  \u003cp\u003eCovering the most recent developments in this field, McCleane offers an alternative solution to pain treatment when conventional treatments fail. This pioneering book proposes evidence-based alternatives to current options in pain management, using well-grounded rationales for each given treatment.\u003c\/p\u003e \u003cp\u003eThis book is an ideal reference for the specialist and non-specialist prescriber alike and for practitioners from a wide variety of disciplines. It provides the evidence required and treatment algorithms for readers to use the drugs appropriately and to explore the field if they wish.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e \u003cb\u003eGary McCleane\u003c\/b\u003e, Consultant in Pain Management, Rampark Pain Centre, Lurgan, Northern Ireland, UK\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e08 July 2008\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781405178235\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e12.8\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44315190460556,"sku":"9781405178235","price":117.85,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781405178235_912bc1d6-ee4b-47fd-9628-f10fa082e030.jpg?v=1780239459"},{"product_id":"9781118755419","title":"Pathology for Toxicologists Principles and Practices of Laboratory Animal Pathology for Study Personnel","description":"\u003ch1\u003ePathology for Toxicologists\u003c\/h1\u003e\u003ch2\u003ePrinciples and Practices of Laboratory Animal Pathology for Study Personnel\u003c\/h2\u003e\u003ch3\u003eElizabeth McInnes\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Toxicology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003eNon-pathologists, such as toxicologists and study personnel, can find it difficult to understand the data they receive from pathologists. Toxicological pathologists write long, detailed and highly technical reports. Study personnel are under daily pressure to decide whether lesions described in pathology reports are treatment-related and thus important  to the pharmaceutical company or whether the lesions are background changes and thus of little significance.\u003c\/p\u003e \u003cp\u003eWritten by experienced toxicological pathologists, \u003ci\u003ePathology for Toxicologists: Principles and Practices of Laboratory Animal Pathology for Study Personnel\u003c\/i\u003e serves to bridge the gap in the understanding of pathology data, enabling non-pathologists to more easily comprehend pathology reports, better integrate pathology data into final study reports and ask pathologists relevant questions about the test compound.\u003c\/p\u003e \u003cp\u003eThis succinct, fully referenced, full colour book is suitable for toxicologists at all stages of their training or career who want to know more about the pathology encountered in laboratory animals used in safety studies.  Key features include important chapters on  spontaneous and target organ lesions in rats, mice, non-human primates, mini pigs, rabbits and beagle dogs as well as information on general pathology, macroscopic target organ lesions, ancillary pathology techniques, haematology, biochemistry and adversity.\u003c\/p\u003e \u003cp\u003e\u003ci\u003ePathology for Toxicologists: Principles and Practices of Laboratory Animal Pathology for Study Personnel \u003c\/i\u003eincludes\u003ci\u003e:\u003c\/i\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eColour diagrams explaining how lesions are caused by either external compounds or spontaneously\u003c\/li\u003e \u003cli\u003eThe anatomic variations and background lesions of laboratory animals\u003c\/li\u003e \u003cli\u003eAdvice on sampling tissues, necropsy, ancillary pathology techniques and recording data\u003c\/li\u003e \u003cli\u003eA chapter on the haematology and biochemistry of laboratory animals\u003c\/li\u003e \u003cli\u003eFull colour photographs of common macroscopic lesions encountered in laboratory animals\u003c\/li\u003e \u003cli\u003eA comprehensive glossary\u003c\/li\u003e \u003c\/ul\u003e\n\u003c\/div\u003e\u003cdiv\u003e   \u003cp\u003e\u003cb\u003e About the Editor\u003cbr\u003e Elizabeth McInnes\u003c\/b\u003e edited the successful \"Background Lesions in Laboratory Animals, A Color Atlas\" (2011) and has published widely on various aspects of toxicological pathology. She qualified as a veterinary surgeon in South Africa in 1988 and completed a PhD at Imperial College, London in 1996. She was awarded Fellowships of the Royal College of Pathologists in 1997 and of the International Academy of Toxicologic Pathology in 2011. She currently runs her own toxicological pathology consultancy business.   \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e08 May 2017\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781118755419\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e216\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e20.8\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44315237941388,"sku":"9781118755419","price":154.76,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781118755419_94a65224-8956-4374-aba4-fc28229d916f.jpg?v=1780203867"},{"product_id":"9781118755402","title":"Pathology for Toxicologists Principles and Practices of Laboratory Animal Pathology for Study Personnel","description":"\u003ch1\u003ePathology for Toxicologists\u003c\/h1\u003e\u003ch2\u003ePrinciples and Practices of Laboratory Animal Pathology for Study Personnel\u003c\/h2\u003e\u003ch3\u003eElizabeth McInnes\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Toxicology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003eNon-pathologists, such as toxicologists and study personnel, can find it difficult to understand the data they receive from pathologists. Toxicological pathologists write long, detailed and highly technical reports. Study personnel are under daily pressure to decide whether lesions described in pathology reports are treatment-related and thus important  to the pharmaceutical company or whether the lesions are background changes and thus of little significance.\u003c\/p\u003e \u003cp\u003eWritten by experienced toxicological pathologists, \u003ci\u003ePathology for Toxicologists: Principles and Practices of Laboratory Animal Pathology for Study Personnel\u003c\/i\u003e serves to bridge the gap in the understanding of pathology data, enabling non-pathologists to more easily comprehend pathology reports, better integrate pathology data into final study reports and ask pathologists relevant questions about the test compound.\u003c\/p\u003e \u003cp\u003eThis succinct, fully referenced, full colour book is suitable for toxicologists at all stages of their training or career who want to know more about the pathology encountered in laboratory animals used in safety studies.  Key features include important chapters on  spontaneous and target organ lesions in rats, mice, non-human primates, mini pigs, rabbits and beagle dogs as well as information on general pathology, macroscopic target organ lesions, ancillary pathology techniques, haematology, biochemistry and adversity.\u003c\/p\u003e \u003cp\u003e\u003ci\u003ePathology for Toxicologists: Principles and Practices of Laboratory Animal Pathology for Study Personnel \u003c\/i\u003eincludes\u003ci\u003e:\u003c\/i\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eColour diagrams explaining how lesions are caused by either external compounds or spontaneously\u003c\/li\u003e \u003cli\u003eThe anatomic variations and background lesions of laboratory animals\u003c\/li\u003e \u003cli\u003eAdvice on sampling tissues, necropsy, ancillary pathology techniques and recording data\u003c\/li\u003e \u003cli\u003eA chapter on the haematology and biochemistry of laboratory animals\u003c\/li\u003e \u003cli\u003eFull colour photographs of common macroscopic lesions encountered in laboratory animals\u003c\/li\u003e \u003cli\u003eA comprehensive glossary\u003c\/li\u003e \u003c\/ul\u003e\n\u003c\/div\u003e\u003cdiv\u003e   \u003cp\u003e\u003cb\u003e About the Editor\u003cbr\u003e Elizabeth McInnes\u003c\/b\u003e edited the successful \"Background Lesions in Laboratory Animals, A Color Atlas\" (2011) and has published widely on various aspects of toxicological pathology. She qualified as a veterinary surgeon in South Africa in 1988 and completed a PhD at Imperial College, London in 1996. She was awarded Fellowships of the Royal College of Pathologists in 1997 and of the International Academy of Toxicologic Pathology in 2011. She currently runs her own toxicological pathology consultancy business.   \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e08 May 2017\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781118755402\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e216\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e15.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44315239121036,"sku":"9781118755402","price":78.26,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781118755402_f75098f0-af71-4e7e-add5-128ce3556862.jpg?v=1780163390"},{"product_id":"9783527314560","title":"Mass Spectrometry in Medicinal Chemistry Applications in Drug Discovery","description":"\u003ch3\u003eMethods \u0026amp; Principles in Medicinal Chemistry\u003c\/h3\u003e\u003ch1\u003eMass Spectrometry in Medicinal Chemistry\u003c\/h1\u003e\u003ch2\u003eApplications in Drug Discovery\u003c\/h2\u003e\u003ch3\u003eKlaus Wanner | Georg Höfner | Raimund Mannhold | Hugo Kubinyi | Gerd Folkers\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Chemistry \/ Industrial \u0026amp; Technical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eThis first overview of mass spectrometry-based pharmaceutical analysis is the key to improved high-throughput drug screening, rational drug design and analysis of multiple ligand-target interactions. The ready reference opens with a general introduction to the use of mass spectrometry in pharmaceutical screening, followed by a detailed description of recently developed analytical systems for use in the pharmaceutical laboratory.\u003cbr\u003e Applications range from simple binding assays to complex screens of biological activity and systems containing multiple targets or ligands -- all highly relevant techniques in the early stages in drug discovery, from target characterization to hit and lead finding.\u003c\/div\u003e\u003cdiv\u003e Klaus T. Wanner studied Chemistry and Pharmacy in Munich and obtained a PhD in Pharmaceutical Chemistry in 1983. He was a postdoctoral fellow in the research group of A. I. Meyers at Colorado State University before taking up a faculty position at the Free University of Berlin. Since 1994, He is a full professor for Pharmaceutical Chemistry at the University of Munich. His main interest is in ligand and inhibitor design for GABA receptors and transporters, as well as in stereochemical aspects of structure-activity relationships.\u003cbr\u003e \u003cbr\u003e Georg C. Hofner studied Pharmacy at the University of Munich and obtained a PhD in Pharmaceutical Chemistry in 1989. He is a specialist on screening technology and is currently supervising the biological assay unit of the Centre of Drug Research at the University of Munich.\u003cbr\u003e \u003cbr\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e16 April 2007\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-VCH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783527314560\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e460\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e34.72\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44315255308428,"sku":"9783527314560","price":272.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783527314560.jpg?v=1780617514"},{"product_id":"9781119117339","title":"Biodegradable and Biobased Polymers for Environmental and Biomedical Applications","description":"\u003ch1\u003eBiodegradable and Biobased Polymers for Environmental and Biomedical Applications\u003c\/h1\u003e\u003ch3\u003eSusheel Kalia | Luc Avérous\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eTechnology \u0026amp; Engineering \/ Chemical \u0026amp; Biochemical\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cb\u003eThis volume incorporates 13 contributions from renowned experts from the relevant research fields that are related biodegradable and biobased polymers and their environmental and biomedical applications.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSpecifically, the book highlights:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eDevelopments in polyhydroxyalkanoates applications in agriculture, biodegradable packaging material and biomedical field like drug delivery systems, implants, tissue engineering and scaffolds\u003c\/li\u003e \u003cli\u003eThe synthesis and elaboration of cellulose microfibrils from sisal fibres for high performance engineering applications in various sectors such as the automotive and aerospace industries, or for building and construction\u003c\/li\u003e \u003cli\u003eThe different classes and chemical modifications of tannins\u003c\/li\u003e \u003cli\u003eElectro-activity and applications of Jatropha latex and seed\u003c\/li\u003e \u003cli\u003eThe synthesis, properties and applications of poly(lactic acid)\u003c\/li\u003e \u003cli\u003eThe synthesis, processing and properties of poly(butylene succinate), its copolymers, composites and nanocomposites\u003c\/li\u003e \u003cli\u003eThe different routes for preparation polymers from vegetable oil and the effects of reinforcement and nano-reinforcement on the physical properties of such biobased polymers\u003c\/li\u003e \u003cli\u003eThe different types of modified drug delivery systems together with the concept of the drug delivery matrix for controlled release of drugs and for antitumor drugs\u003c\/li\u003e \u003cli\u003eThe use of nanocellulose as sustainable adsorbents for the removal of water pollutants mainly heavy metal ions, organic molecules, dyes, oil and CO\u003csub\u003e2\u003c\/sub\u003e\n\u003c\/li\u003e \u003cli\u003eThe main extraction techniques, structure, properties and different chemical modifications of lignins\u003c\/li\u003e \u003cli\u003eProteins and nucleic acids based biopolymers \u003c\/li\u003e \u003cli\u003eThe role of tamarind seed polysaccharide-based multiple-unit systems in sustained drug release \u003c\/li\u003e \u003c\/ul\u003e\n\u003c\/div\u003e\u003cdiv\u003e  \u003cp\u003e\u003cstrong\u003eSusheel Kalia\u003c\/strong\u003e?is an associate professor in the Department of Chemistry at Bahra University, Solan, India. He has around 65 research papers in international journals along with 80 publications in national and international conferences and many book chapters. He has edited a number of books including?\u003cem\u003eBiopolymers: Biomedical and Environmental Applications\u003c\/em\u003e?(Wiley-Scrivener, 2011). \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuc Avérous\u003c\/strong\u003e?is a Group Leader, Head of Polymer Research Department in an institute (ICPEES-UMR CNRS 7515) at University of Strasbourg (France), and former Lab Director. In 2003, he became a Full Professor at ECPM (University of Strasbourg), where he teaches polymer science and engineering. During the last two decades, his major research projects have dealt with biobased and\/or biodegradable polymers for environmental \u0026amp; biomedical applications. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e29 February 2016\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Scrivener\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781119117339\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e520\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e28.32\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44315278639244,"sku":"9781119117339","price":239.36,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781119117339.jpg?v=1780207295"}],"url":"https:\/\/fh90cf-fv.myshopify.com\/collections\/pharmacology.oembed?page=10","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}